Skip to main content
Erschienen in:

Open Access 10.06.2024 | Review

Exploring the utility of retinal optical coherence tomography as a biomarker for idiopathic intracranial hypertension: a systematic review

verfasst von: Mallika Prem Senthil, Saumya Anand, Ranjay Chakraborty, Jose Estevez Bordon, Paul A. Constable, Shannon Brown, Dalia Al-Dasooqi, Simu Simon

Erschienen in: Journal of Neurology | Ausgabe 8/2024

Abstract

This study aimed to examine the existing literature that investigated the effectiveness of optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A) as a biomarker for idiopathic intracranial hypertension (IIH). Our search was conducted on January 17th, 2024, and included the databases, Medline, Scopus, Embase, Cochrane, Latin American and Caribbean Health Sciences Literature (LILACS), International Standard Randomized Controlled Trial Number (ISRCTN) registry, and the International Clinical Trials Registry Platform (ICTRP). Our final review included 84 articles. In 74 studies, OCT was utilized as the primary ocular imaging method, while OCT-A was employed in two studies including eight studies that utilized both modalities. Overall, the results indicated that IIH patients exhibited significant increases in retinal nerve fiber layer (RNFL) thickness, total retinal and macular thickness, optic nerve head volume, and height, optic disc diameter and area, rim area, and thickness compared to controls. A significant correlation was observed between cerebrospinal fluid (CSF) pressure and OCT parameters including RNFL thickness, total retinal thickness, macular thickness, optic nerve head volume, and optic nerve head height. Interventions aimed at lowering CSF pressure were associated with a substantial improvement in these parameters. Nevertheless, studies comparing peripapillary vessel density using OCT-A between IIH patients and controls yielded conflicting results. Our systematic review supports OCT as a powerful tool to accurately monitor retinal axonal and optic nerve head changes in patients with IIH. Future research is required to determine the utility of OCT-A in IIH.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00415-024-12481-3.

Introduction

Idiopathic intracranial hypertension (IIH) is a disorder of unknown etiology characterized by raised intracranial pressure (ICP) that predominantly affects obese women of childbearing age [1]. The prevalence of IIH in the general population is 1–3 per 100,000 people but among women of childbearing age, the prevalence rate is higher at 5.5 per 100,000 [25]. The incidence of IIH has increased due to the rapid increase of obesity and the estimated total cost of IIH in the USA alone has exceeded USD $444 million [6]. Although the exact cause of IIH is unknown, several theories have been postulated, including increased abdominal pressure, sleep apnea syndrome, reduction in cerebrospinal fluid (CSF) outflow or elevated venous sinus pressure [79]. The predominant symptom of IIH is headache, which can vary in intensity from mild to severe [10, 11] and chronic headache has been shown to significantly impact the quality of life of individuals with IIH [12, 13]. Other symptoms of IIH include tinnitus, visual obscuration, and diplopia [1, 10, 14, 15]. The accepted criteria for diagnosis of IIH includes the combination of raised ICP without hydrocephalus or mass lesions, normal CSF composition, and normal neuroimaging [13]. There are currently no evidence-based guidelines for the medical and surgical management of IIH due to a lack of information on the efficacy of treatments and possible side effects [16, 17].
Chronic elevated ICP can lead to cerebral ischemia, cerebral edema, herniation, irreversible brain damage and in severe cases, death [18]. Hence, the precise measurement and continuous monitoring of ICP are crucial in caring for patients with IIH [19]. ICP can be accurately assessed using lumbar and transcranial methods but are invasive and carry an increased risk of bleeding and infection [20, 21]. Several non-invasive methods such as magnetic resonance imaging, computerized axial tomography imaging, transcranial doppler ultrasonography, tympanic membrane displacement, and ocular ultrasound have also been used to monitor the ICP changes in patients with raised IIH. However, these methods have limitations such as low sensitivity and specificity, poor inter-rater reliability, and poor test predictability [22]. Therefore, more accurate and reliable biomarkers are needed to evaluate the disease state.
Optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A) are imaging modalities that provides qualitative and quantitative evaluation of the changes in the retinal nerve fibre layer (RNFL), optic nerve head, macula, and retinal and choroidal perfusion. While OCT can provide structural information about the retina and choroid, OCT-A provides information about the vasculature and blood flow of the retina and choroid (Table 1). OCT/OCT-A are routinely used in ophthalmic clinical settings to diagnose and monitor retinal conditions such as diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusions [2329]. OCT allows visualization of optic nerve head swelling, changes in the RNFL and retinal pigment epithelium/Bruch’s membrane (RPE/BM) layer associated with acute and chronic changes in ICP. In addition, OCT-A allows the evaluation of vessel density on the optic disc and peripapillary region in both newly diagnosed and chronic IIH cases, making these imaging modalities valuable tools for both diagnosing and monitoring IIH [30, 31]. OCT can be useful to differentiate true disc edema, including papilledema from pseudoedema due to optic disc drusen. Studies have shown that RNFL thickness particularly in the nasal and inferior quadrants were reduced in optic disc drusen compared to optic disc edema [32, 33]. The standard for evaluating the severity of papilledema is the Frisén scale which grades the optic disc swelling from 0 to 5. Three-dimensional OCT parameters such as optic nerve head volume, height, and shape could potentially offer greater sensitivity compared to the Frisén scale in evaluating treatment outcomes among IIH patients [34]. This is because even in IIH patients with normal RNFL thickness, the optic nerve head volume has been shown to be elevated [35]. The configuration of the RPE/BM layer in OCT scans can aid in distinguishing papilledema from disc edema caused by other factors like anterior ischemic optic neuropathy (AION). In papilledema, the RPE/BM layer exhibits a U-shape, angled toward the vitreous, whereas in AION and normal individuals, it assumes a V-shaped configuration, angled away from the vitreous [36, 37]. Increased ICP in IIH can cause biomechanical stress on the optic nerve head and retina resulting in retinal and choroidal folds, and OCT has been shown to be more sensitive than fundus photography is detecting these folds [38]. Quantitative assessments of vessel density surrounding the optic nerve head have shown a reduction in disorders such as optic neuritis, arteritic anterior ischemic optic neuropathy (AAION), and optic atrophy [39]. As such, the usefulness of OCT-A in diagnosing and monitoring IIH is still unclear. This systematic review examined the current body of literature regarding the utilization of OCT/OCT-A as a biomarker for IIH and reports the most suitable OCT/OCT-A parameters for the diagnosis and monitoring of IIH.
Table 1
Comparison of optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A) imaging techniques
 
Optical coherence tomography (OCT)
Optical coherence tomography angiography (OCT-A)
Key components
It is a three-dimensional technique
Optical coherence tomography uses infrared light directed toward the tissue under examination. The reflected light waves are then analyzed for time delay and differences in signal strength, which allows for assessment of tissue depth and imaging at the selected location
The axial resolution of various OCTs is between 5 and 20 μm in the tissue
It is a three-dimensional technique
Optical coherence tomography angiography uses low coherence interferometry with a focus on motion contrast of red blood cells for vascular imaging. The differences in the reflected OCT signal strength from consecutive OCT B-scans captured at the same location are used to generate an image of the blood flow
The resolution of the instrument is 5–10 μm in the axial direction and ∼20 μm in the transverse direction
Strengths
Cross-sectional retinal imaging providing detailed imaging of the retinal, choroidal, and optic nerve head structure
Rapid image generation, with processing completed in seconds
Non-invasive
Portable
Detailed imaging of the retinal, choroidal, and optic nerve head vasculature and perfusion
Quantitative imaging on vascular density and perfusion
Rapid image generation, with processing completed in seconds
Enables imaging of the retinal vascular flow without the need for injection of a dye
Non-invasive
Portable
Limitations
Inability to image blood flow
Motion artifacts during imaging can lower the quality of the image
It lacks the ability to show vascular leakage
Small field of view
Presence of artifacts can hinder accurate interpretation of the image
Image
https://static-content.springer.com/image/art%3A10.1007%2Fs00415-024-12481-3/MediaObjects/415_2024_12481_Figa_HTML.jpg
https://static-content.springer.com/image/art%3A10.1007%2Fs00415-024-12481-3/MediaObjects/415_2024_12481_Figb_HTML.jpg

Methods

This systematic review followed the reporting guidelines outlined in the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) and was registered with the International Prospective Register of Systematic Reviews (PROSPER; ID: CRD42024520282). An initial search was performed using Medline and CINAHL to identify relevant articles and keywords. An extensive search strategy was then developed in Medline based on the identified keywords and index terms. The keywords used for the search included: “idiopathic intracranial hypertension”, “pseudotumor cerebri”, “pseudotumor syndrome”, “Nonne’s syndrome”, “otitis hydrocephalus”, “benign intracranial hypertension”, “non-infective serous meningitis”. The retrieved articles from the Medline search were evaluated to confirm the inclusion of key publications. The search strategy, including the keywords and index terms, were adapted for other bibliographic databases such as PsycINFO (via Ovid SP), Latin American and Caribbean Health Sciences Literature (LILACS) and Scopus (Elsevier) (Online Resource 1). Each database search strategy was run on 17 January 2024. In addition, grey literature sources were searched including the International Standard Randomized Controlled Trial Number (ISRCTN) registry and the International Clinical Trials Registry Platform (ICTRP). There were no limits applied to language, but studies were excluded if they were solely animal studies, case report/case series, editorials, reviews, or conference abstracts. The primary outcome was to report the retinal and optic nerve head changes using OCT/OCT-A in IIH patients. Two authors (MPS and JE) independently evaluated the titles and abstracts and then full-text reports for relevance utilizing Covidence (IBM, Detroit USA). Any discrepancies in the screening were resolved by mutual consensus between the authors. Reasons for exclusion of the studies were reported in each step of the review process. Included studies were assessed for quality according to the National Institutes of Health Quality Assessment Tool for observational cohort, case–control, cross-sectional, before–after studies with no control groups and controlled intervention studies. The assessment of case–control and before–after studies included 12 items scored as “yes”, “no”, or “other” (cannot determine, not applicable, not reported). The assessment of cohort, observational, and controlled intervention studies included 14 items that were again scored as “yes”, “no” or “other” (cannot determine, not applicable, not reported).

Results

Our initial search yielded 852 articles. Upon reviewing titles and abstracts, 718 articles were excluded (Fig. 1). After examining the full text of the remaining articles, an additional 50 were excluded. The final review comprised 84 articles that utilized ocular imaging as a biomarker for IIH (Table 2). We categorized the included articles into two groups: (1) studies employing OCT as the imaging technique in IIH, and (2) studies employing OCT-A as the imaging technique in IIH. The assessment of the risk of bias of the studies included in this review is shown in Online Resource 2.
Table 2
Summary of the studies included in the systematic review
Author
Year
Country
Study design
Sample size
Imaging
Device
Results
Rebolleda et al. [40]
2009
Spain
Case–control
IIH = 22
Controls = 22
OCT
Stratus OCT
The mean retinal nerve fibre layer (RNFL) and RNFL thickness in all quadrants in the eyes with papilledema were significantly greater than that of controls
Jensen et al. [64]
2010
Denmark
Case–control
IIH = 20
Controls = 20
OCT
Stratus OCT 3000
Baseline average RNFL and retinal thickness were significantly higher in patients with IIH compared to control
Scott et al. [65]
2010
USA
Cross-sectional
Papilledema = 36
OCT
OCT3
There was a significant correlation between OCT RNFL thickness, OCT total retinal thickness and modified Frisén scale (MFS) grades from photographs
Sinclair et al. [93]
2010
UK
Cross-sectional
IIH = 25
OCT
Stratus OCT
Elevation of the optic disc, diameter of the optic nerve sheath, and thickness of peripapillary RNFL significantly improved after weight loss
Sibony et al. [36]
2011
USA
Case–control
Papilledema = 25
AION = 20
Controls = 30
OCT
Cirrus
OCT
The retinal pigment epithelium-basement membrane (RPE/BM) layer in controls and anterior ischemic optic neuropathy has a V-shape pointing away from vitreous. However, papilledema has a U shape pointing toward vitreous. Weight loss and shunting moved the U shape to V shape in papilledema patients
Skau et al. [136]
2011
Denmark
Case–control
IIH = 20
OCT
Stratus OCT 3000
Peripapillary OCT is a promising objective examination modality for optic disc evaluation in IIH and may improve the identification of subtle disc swellings
Skau et al. [66]
2011
Denmark
Case–control
IIH = 17
Controls = 20
OCT
Stratus OCT 3000
At baseline, average RNFL thickness and retinal thickness were significantly higher in IIH compared to controls. Changes in visual field mean deviation and pattern deviation from baseline to the final visit correlated significantly with OCT changes. During follow-up, patients improved significantly in OCT parameters and visual field sensitivity
Waisbourd et al. [41]
2011
Israel
Cross-sectional
IIH = 48
OCT
OCT3
3000
Average RNFL thickness was statistically different between the groups: the normal optic disc/mild elevation group, moderate elevation group, and the full-blown papilledema group
Kaufhold et al. [35]
2012
Germany
Case–control
IIH = 19
Controls = 19
OCT
Spectralis OCT
The 3D parameters, optic nerve head volume (ONHV), and optic nerve head height (ONHH) were able to discriminate between controls, treated, and untreated patients. Both ONHV and ONHH measures were related to levels of intracranial pressure (ICP)
Yri et al. [67]
2012
Denmark
Case–control
IIH = 18
Controls = 20
OCT
Stratus OCT
3000
IIH patients with resolved papilledema at follow-up had a significant reduction in RNFL and retinal thickness values from 3-month follow-up visit to the final follow-up. At final follow-up, RNFL and retinal thickness were significantly thinner in IIH patients than healthy controls
Marzoli et al. [42]
2013
Italy
Cross-sectional
IIH = 38
OCT
RTVue-100 OCT
Mean average peripapillary retinal nerve fibre layer (ppRNFL) thickness was greater than normal values, while mean average macular ganglion cell complex thickness was lower than normal values
Skau et al. [43]
2013
Denmark
Case–control
IIH = 20
Controls = 20
OCT
Stratus OCT 3000
RNFL thickness was significantly increased in for all disc quadrants in newly diagnosed IIH
Auinger et al. [68]
2014
USA
Cross-sectional
IIH = 126
Controls
OCT
Cirrus OCT
4000
3D segmentation-based applications appear to be superior to commercially available 2D algorithms for calculating thickness of RNFL, total retinal thickness, and ganglion cell layer
Fard et al. [44]
2014
Iran
Case–control
Papilledema = 21
Pseudopapilledema = 19
Controls = 17
OCT
Spectralis OCT
RNFL thickness significantly increased in mild papilledema and pseudopapilledema compared to controls. Outer peripapillary total retinal volume is increased in only papilledema compared with pseudopapilledema and controls
Sibony et al. [19]
2014
USA
Pre–Post
IIH = 41
Controls = 30
OCT
Cirrus OCT
The ppRPE/BM changes with CSF pressure lowering interventions. Direct measurements of displacement at the basement membrane opening may serve as a more convenient office-based surrogate for shape analysis
Monteiro et al. [72]
2014
Brazil
Case–control
IIH = 29
Controls = 31
OCT
Cirrus OCT
The RNFL thickness and macular thickness significantly reduced in resolved papilledema compared to controls. Both measurements correlated with visual field sensitivity loss
OCT sub-study committee [34]
2015
USA
RCT
IIH = 89
OCT
Cirrus OCT
4000
RNFL thickness, total retinal thickness, and ONHV measurements improved with Diamox and weight loss
Chang et al. [89]
2015
USA
Case–control
IIH = 11
Controls = 11
OCT
Cirrus OCT
Mean OCT measurements of optic nerve protrusion length (NPL) were significantly larger than in controls. OCT and MRI measurements of NPL significantly correlated and significantly associated with Frisén papilledema grade
Chen et al. [76]
2015
USA
Cross-sectional
IIH = 31
OCT
Cirrus OCT
4000
A ganglion cell layer-inner plexiform layer (GCL-IPL) thickness less than or equal to 70 µm at initial presentation or progressive thinning greater than or equal to 10 µm with 2–3 weeks compared with baseline correlated with poor visual outcome
Afonso et al. [137]
2015
Brazil
Case–control
PTC = 24
Controls = 26
OCT
3D OCT-1000
Both pattern electroretinogram (PERG) N95 amplitude and OCT parameters were able to discriminate papilledema eyes from controls with a similar performance. There was a significant correlation between PERG amplitude values and OCT parameters
Goldhagen et al. [73]
2015
USA
Case–control
IIH = 43
Controls = 30
OCT
Spectralis OCT
Total macular thickness was significantly thinner within the fovea and inner macular ring in non-trophic papilledema vs controls
Labib et al. [77]
2015
Egypt
Case–control
IIH = 30
OCT
RTVue SD-OCT
Initial RNFL thickness was significantly higher whereas macular ganglion cell complex (GCC) was significantly lower than controls. Macular GCC and RNFL thickness correlated with visual field loss
Moss et al. [78]
2015
USA
Case–control
IIH = 10
Controls = 15
OCT
Spectralis OCT
Photopic negative response was decreased in IIH patients and correlated with chronic ganglion cell injury and clinical measure of acute optic nerve head pathology
Sibony et al. [94]
2015
USA
Cross-sectional
IIH = 165 eyes
OCT
Cirrus OCT
4000
Folds are common in IIH and are three basic patterns: peripapillary wrinkles, retinal folds, and choroidal folds. OCT, specifically the raster and en face imaging, appears to be more sensitive in detecting folds than color fundus photography
Starks et al. [45]
2016
USA
Cross-sectional
IIH = 13
OCT
Stratus OCT
The visual field pattern deviation and RNFL are improved after optic nerve sheath fenestration
Dinkin et al. [46]
2017
USA
Pre–Post
IIH = 13
OCT
Cirrus OCT
Stenting of venous sinus stenosis is safe and results in reduction of ICP in IIH patients. This is associated with improvement in papilledema, RNFL thickness, visual field parameters and symptoms
Gampa et al. [96]
2017
USA
Pre–Post
IIH = 20
OCT
Spectralis OCT
This study demonstrates a quantitative association between pp-BM shape and chronic ICP level. Changes in pp-BM shape is detectable within 1 h of lowering ICP. pp-BM shape may be a useful marker for chronic ICP level and acute ICP changes
Albrecht et
al [86]
2017
Germany
Case–control
IIH = 21
Controls = 27
OCT
Spectralis OCT
In IIH, the ONHV increased and correlated with CSF pressure. The ONHV decreased after the initiation of treatment with Diamox
Kupersmith et al. [37]
2017
USA
Cross-sectional
IIH = 87
OCT
Cirrus OCT
4000
The various types of retinal folds associated with papilledema reflect biodynamic processes and show an acetazolamide treatment effect. Persistence of these folds, despite marked improvement in optic nerve head swelling, suggests permanent changes in the affected retinal tissues
Saenz et al. [47]
2017
USA
Cross-sectional
Papilledema = 23
Pseudopapilledema = 28
OCT
Cirrus OCT
4000
Compared to pseudopapilledema, papilledema eyes showed larger mean optic nerve sheath diameter, thicker RNFL
Wang et al. [30]
2017
USA
Cross-sectional
IIH = 125
OCT
Cirrus OCT
4000
Mean changes of the pRPE/BM shape measure were significant and in the positive direction (away from the vitreous) for the acetazolamide, but not for the placebo group
Aojula et al. [48]
2018
UK
Case–control
IIH = 46
Controls = 14
OCT
Spectralis OCT
Significantly greater thickness automated segmentation error (SegE) was present in RNFL thickness total area, assessed using ImageJ, in IIH patients compared to controls
Park et al. [79]
2018
USA
Case–control
IIH = 11
Controls = 11
OCT
Spectralis OCT
Mean full field photopic negative response (ffPhNR) amplitude was reduced significantly in the patients compared to controls. The pattern pERG amplitude correlated significantly with Humphrey visual field mean deviation and GCC volume. However, the fPhNR amplitude was not correlated significantly with Humphrey visual field mean deviation or GCC volume
Sheils et al. [87]
2018
USA
Cross-sectional
IIH = 126
Controls
OCT
Cirrus OCT
Correlations between disc area and optic nerve head volume were similar in the treatment groups at baseline but were weaker in the acetazolamide group compared with the placebo group at 6 and 12 months in study eyes
Banki et al. [97]
2019
USA
RCT
IIH = 165
OCT
Cirrus OCT
4000
The change in CSF pressure did not correlate with the change in IOP for either treatment group. There was no correlation between the CSF pressure and the optic nerve head (ONH) shape or CSF pressure-IOP pressure and ONH shape at baseline or at 6 months
Eren et al. [90]
2019
Turkey
Case–control
IIH = 54
Controls = 48
OCT
RTVue SD-OCT
The mean RNFL thickness was greater in the control group compared to IIH patients. The disc area, rim area was higher in the IIH group compared to controls, but the cup volume was lesser in the IIH group. There was a positive correlation between papilledema grade, rim area, RNFL thickness, CSF opening pressure, disc area, and rim area
Huang-Link et al. [49]
2019
Sweden
Case–control
IIH with papilledema = 8
IIH without papilledema = 9
Other neurological diseases = 19
OCT
Cirrus OCT
4000
IIH patients with papilledema had increased RNFL compared to IIH without papilledema and neurological diseases. RNFL reduced after CSF removal at 3 and 6 months in IIH patients with papilledema. However, no significant change in RNFL thickness after CSF removal was observed in IIH without papilledema or in patients with other neurological diseases
Onder et al. [50]
2019
Turkey
Cross-sectional
IIH = 18
OCT
Cirrus OCT
5000
There was a significant correlation between LP opening pressure and RNFL thickness. No association between RNFL measurements and MRI signs. Patients with IIH showed increased rim area and rim thickness but reduced optic cup volume
Pasaoglu et al. [99]
2019
Turkey
Case–control
IIH = 8
Controls = 10
OCT
Spectralis OCT
There was a significant difference in the anterior lamina cribrosa surface depth and the posterior lamina cribrosa surface depth between IIH patients and controls. No significant difference in lamina cribrosa thickness between IIH and controls
Merticariu et al. [51]
2019
Romania
Case–control
IIH = 11
Controls = 13
OCT
DRI Oct Triton
There was a significant difference in the average RFNL thickness between IIH and controls. There was also a correlation between papilledema severity and RNFL thickness
Wall et al. [52]
2019
USA
Case–control
IIH = 39
Controls = 98
OCT
Cirrus 5000 OCT
Although the presence of papilledema limited correlation, 55% of the temporal wedge defects had OCT RNFL deficits in the corresponding superonasal location
Vijay et al. [88]
2020
UK
Cross-sectional
IIH = 104
OCT
Spectralis OCT
ONHV on OCT correlated with ICP. OCT can be used as a surrogate to inform ICP changes
Chen et al. [80]
2020
China
Cross-sectional
Primary PTCS = 9
Secondary PTCS = 46
OCT
Cirrus OCT
Secondary pseudotumor cerebri syndrome (PTCS) is more common than primary PTCS. OCT showed that eyes with intact macular GCL-IPL at baseline had good outcomes after treatment
Dreesbach et al. [103]
2020
Germany
Case–control
IIH = 21
Control eyes = 25
OCT
Spectralis OCT
ONHV was significantly increased in IIH compared to controls. The Frisén scale grading correlated higher with the ONHV than with RNFL thickness
Bahnasy et al. [53]
2020
Egypt
Cross-sectional
IIH with medical treatment = 59
IIH with LPS = 9
OCT
Spectralis OCT
Patients needed lumboperitoneal shunt showed statistically significant increase in baseline papilledema grade, mean deviation of visual field examination, optic nerve sheath diameter, average OCT–RNFL thickness, and P100 pattern reversal visual evoked potential latency. On the other hand, both studied groups showed statistically nonsignificant differences regarding the patients’ ages and opening CSF pressure
Tatar et al. [100]
2020
Turkey
Case–control
IIH = 15
Controls = 17
OCT
EDI-OCT
Prelaminar tissue thickness and Bruch’s membrane opening were significantly greater in IIH than controls. Anterior lamina cribrosa surface depth was significantly less in IIH than controls. No difference regarding lamina cribrosa thickness between IIH and controls
Ozdemir et al. [101]
2020
Turkey
Case–control
IIH = 22
Controls = 22
OCT
3D OCT-2000
IIH patients had increased RNFL thickness and choroidal thickness compared to controls. Subfoveal choroidal thickness was significantly correlated with ICP
Flowers et al. [54]
2021
USA
Cross-sectional
Papilledema = 22
Pseudopapilledema = 36
OCT
Cirrus OCT
The papilledema group had a higher mean RNFL thickness than the pseudopapilledema group
Nogueira et al. [81]
2021
Brazil
Case–control
IIH = 22
Controls = 11
OCT
RTVue-100
There was a significant association between macular GCC thickness and optic disc pallor and between edema and visual acuity. No significant difference was found in RNFL thickness between patients and controls. Macular GCC was thinner in patients with IIH compared to controls
Bingol Kiziltuncet et al. [69]
2021
Turkey
Cross-sectional
IIH = 28
OCT
RTVue XR OCT
Bruch’s membrane opening and maximal RNFL thickness were significantly higher in patients with increased CSF pressure. There exist correlations between CSF pressure and Bruch’s membrane opening, maximal RNFL thickness and maximal retinal thickness. Bruch’s membrane opening and maximal RNFL thickness can give an idea about increased CSF pressure values in IIH patients
Carey et al. [55]
2021
USA
Cross-sectional
IIH = 2 (20 scans)
OCT
Cirrus OCT
Multiple objective parameters of en face OCT of optic disc edema have an excellent correlation with ppRNFL thickness
Kabatas et al. [74]
2021
Turkey
Case–control
IIH = 56
Controls = 50
OCT
RTVue-XR 100 OCT
There was a significant difference in the mean RFNL thickness between IIH and controls. There was a significant positive correlation between the peripapillary RNFL thickness, the GCC thickness, and the CSF opening pressure. A similar result was also found between the Frisén grade and peripapillary RNFL
Kohil et al. [56]
2021
USA
Cross-sectional
Papilledema = 25
Pseudopapilledema = 24
OCT
Cirrus 5000 OCT
Ocular ultrasonography was 68% sensitive for papilledema and 54% specific for pseudopapilledema. Positive OUS correlated with elevated opening pressure on lumbar puncture and with signs of increased ICP on MRI
Panyala et al. [98]
2021
India
Case–control
Papilledema = 30
Papillitis = 30
Controls = 80
OCT
Cirrus OCT
97% of the eyes with papilledema had positive ppRPE/BM angle and 97% of the eyes with papillitis had negative ppRPE/BM angle. At 1 month, both RNFL thickness and ppRPE/BM reduced significantly in eyes with papilledema. RNFL normalized in 3 months and RPE/BM normalized in 6 months in patients with papilledema
Reggie et al. [95]
2021
USA
Cross-sectional
Papilledema = 32
Pseudopapilledema = 46
OCT
Cirrus 5000 OCT
Choroidal and/or retinal folds on OCT are commonly observed in patients with mild papilledema and are uncommon in those with pseudopapilledema
Touzé et al. [84]
2021
Canada
Cross-sectional
IIH = 16
OCT
Cirrus OCT
Mean RNFL was significantly decreased 1 month after stenting and at last visit. Ganglion cell thickness moderately decreased after stenting
Wibroe et al. [82]
2021
Denmark
Cross-sectional
IIH = 32
OCT
Spectralis OCT
The high prevalence of hyperreflective lines and peripapillary hyperreflective ovoid mass-like structures in IIH patients suggest these structures be a result of crowding in the optic nerve head caused by papilledema
Banerjee et al. [138]
2022
India
Case–control
IIH = 27
OCT
Cirrus OCT
4000
At baseline, average RNFL had a moderate negative correlation with mean deviation and a positive correlation with log MAR visual acuity. Baseline GCL and log MAR visual acuity had a negative correlation. Optic disc height (ODH) had a negative correlation with visual field mean deviation. At 6 months, ODH and GCL-IPL complex had a statistically significant correlation with functional parameters
Inam et al. [57]
2022
USA
Cross-sectional
IIH = 53
OCT
SD-OCT
The mean changes in OCT RNFL and mean deviation in Humphrey visual field at 6 weeks were not different between low, medium, and high venous sinus pressure gradient
Jacobsen et al. [7]
2022
Norway
Case–control
IIH = 20
Controls = 12
OCT
Nidek’s SD-OCT 3000
The peripapillary Bruch’s membrane angle (pBA) and the ONHH differed between the IIH and reference groups and correlated with both mean ICP wave amplitude and mean ICP
Thaller et al. [58]
2022
UK
Cross-sectional
IIH = 123
OCT
SD-OCT
Increased weight gain during lockdown was associated with significant increase in papilledema (RNFL). RNFL thickness was reduced in patients with weight loss
Rehman et al. [91]
2022
India
Cross-sectional
IIH = 30
OCT
Cirrus OCT
A statistically significant change was observed in all OCT parameters during the 6-month follow-up (RNFL thickness, disc area, rim area, ONHV, mean retinal thickness, choroidal thickness)
Rehman et al. [75]
2022
India
Cross-sectional
IIH = 10
OCT
Cirrus OCT
Statistically significant difference in RNFL thickness and macular thickness in nasal quadrant was seen between the eyes with recurrence and without recurrence
Sood et al. [59]
2022
India
Cross-sectional
Optic disc edema = 64
(IIH = 10)
OCT
Cirrus OCT
The clinical severity of optic disc edema correlated positively with RNFL thickness, and most of the categories of optic disc edema followed the normative pattern of RNFL thickness (inferior > superior > nasal > temporal) despite thickening
Vosoughi et al. [60]
2022
Canada
Cross-sectional
IIH = 186
OCT
Cirrus 5000 OCT
Patients seeking care due to symptoms of IIH also had higher RNFL thickness, worse visual function, a higher, LP opening pressure, and worse final visual outcome
Attia et al. [70]
2023
France
Cross-sectional
IIH = 49
Intracranial tumors = 33
Cerebral venous thrombosis = 15
OCT
Spectralis OCT
Mean RNFL thickness and retinal thickness was significantly different between the optic atrophy and no atrophy group
Kaya et al. [92]
2023
Turkey
Case–control
IIH = 43
Controls = 20
OCT
RTVue OCT
In the resolved-papilledema subgroup, peripapillary choroidal thickness in all quadrants was significantly lower than in the control group. In the acute-papilledema subgroup, peripapillary choroidal thickness in the temporal, inferior, and superior quadrants was significantly less than in the control eyes. The disc diameters in the vertical and horizontal planes was also significantly larger in the acute-papilledema eyes than in the control eyes and in the resolved papilledema eyes
Kaya Tutar et al. [61]
2023
Turkey
Cross-sectional
IIH = 21
OCT
Spectralis OCT
A statistically significant positive and moderate correlation was found between CSF pressure values and average RNFL thickness
Thaller et al. [139]
2023
UK
Cross-sectional
IIH = 490
OCT
Spectralis OCT
Those with the highest OCT RNFL had the worst visual outcomes
Thaller et al. [85]
2023
UK
Cross-sectional
IIH = 343
OCT
Spectralis OCT
OCT parameters did not differ significantly between symptomatic and asymptomatic disease
Xie et al. [62]
2023
Canada
Cross-sectional
IIH = 165
OCT
Cirrus OCT
Papilledema recurrence can be detected in atrophic optic discs using OCT
Bassi et al. [83]
2024
India
Cross-sectional
IIH = 20
OCT
SD-OCT
The RNFL thickness in all four quadrants had a weak positive correlation, and the GCL-IPL layer had a weak negative correlation with the ICP
Srija et al. [63]
2024
India
Case–control
Optic disc edema = 81
Controls = 74
OCT
Topcon 3D-OCT
Peripapillary RNFL thickness was significantly increased in the optic disc oedema group compared to controls
Wang et al. [71]
2024
USA
Case–control
IIH = 125
Controls = 96
OCT
Cirrus OCT
The montage colormaps of RNFL and total retinal thickness produced by the biVAE model provided an organized visualization of the variety of morphological patterns of optic disc oedema (including differing patterns at similar thickness levels)
Yalcinkaya Cakir et al. [108]
2023
Turkey
Case–control
IIH = 30
ODD = 33
Controls = 70
OCT & OCT-A
Topcon
Peripapillary vascular density is reduced in patients with IIH and optic disc drusen (ODD) compared to healthy controls. There is a significant difference in the vascular density in deep capillary plexus and choriocapillaris between IIH and ODD
Fard et al. [110]
2019
Iran
Case–control
Papilledema = 21
Pseudopapilledema = 15
Controls = 44
OCT & OCT-A
AngioVue
Average RNFL was greater in patients with papilledema compared to pseudo and controls. No difference in GCC thickness between the three groups. Peripapillary vasculature values were significantly lower in papilledema and pseudo compared to controls
Rodriguez Torres et al. [140]
2021
USA
Cross-sectional
IIH = 23
OCT & OCT-A
AngioVue
Skeletonized vessel density peripapillary capillary plexus was significantly associated with papilledema grades, RNFL thickness, GCL thickness. Increased grading was associated with decrease of vessel density
El-Haddad et al. [141]
2023
Egypt
Cross-sectional
IIH = 21
OCT-A
AngioVue
Optic disc vessel density decreased after shunt surgery in patients with IIH. There were positive correlations between the CSF opening pressures and the preoperative optic disc vessel density of the whole image and inside disc. In addition, there was a positive correlation between the opening CSF pressures and the reduction in whole image vessel density after surgery
Wang et l [111]
2023
China
Case–control
IIH = 61
Controls = 65
OCT & OCT-A
VG200S, Svision
Patients with IIH showed thicker ppRNFL and GCL-IPL thickness with larger ONH rim area when compared to controls. Microvascular densities were increased in nerve fibre layer plexus while densities were reduced in superficial vascular plexus, intermediate capillary plexus, and deep capillary plexus compared to controls
Pahuja et al. [102]
2023
India
Case–control
IIH = 41
Controls = 10
OCT & OCT-A
Angioplex
RNFL thickness showed significant thinning in the early, chronic, and atrophic papilledema. GC-IPL was significantly reduced in all groups compared to controls
Kwapong et al. [113]
2023
China
Case–control
IIH = 46
Controls = 42
OCT & OCT-A
VG200S, Svision
Compared with the control group, IIH patients showed reduced microvascular densities and thinner retinal thicknesses. ICP correlated with the microvascular densities and GCL-IPL thickness in IH patients for superficial vascular complex and deep vascular complex
Chonsui et al. [112]
2022
France
Cross-sectional
Papilledema = 20
Controls = 33
OCT & OCT-A
PLEX Elite
There was a decreased peripapillary capillary density without changes in capillary flux intensity (CFI) in eyes with papilledema. There were a positive association between the CFI and the RNFL and a negative association between the capillary perfusion density (CPD) and the RNFL
Kaya et al. [109]
2021
Turkey
Case–control
IIH = 31
Controls = 52
OCT-A
AngioVue
The vessel density in the inferior nasal region in IIH patients significantly exceeded the vessel density of the controls. RFNL and GCC thickness were comparable between IIH and controls
Tüntaş Bilen et al. [107]
2019
Turkey
Case–control
IIH = 19
Controls = 21
OCT & OCT-A
AngioVue
There was a decrease in peripapillary density in patients with IIH compared to health controls
RCT randomized controlled trail; IIH idiopathic intracranial hypertension; AION anterior ischemic optic neuropathy; PTC pseudotumor cerebri; PTCS pseudotumor cerebri syndrome; LPS lumboperitoneal shunt; ODD optic disc drusen; OCT optical coherence tomography; OCT-A optical coherence tomography angiography; CSF cerebrospinal fluid; ICP intracranial pressure

Studies investigating OCT as the imaging modality in IIH

There were 82 studies that used OCT as an imaging modality in IIH. In these studies, OCT imaging was used to evaluate treatment effectiveness in patients with IIH, to compare the retinal and optic nerve head changes between IIH patients and healthy controls or to ascertain the relationship between OCT measurements and clinical parameters. The following OCT parameters were compared among the studies that reported them: peripapillary RNFL thickness [4063], total retinal thickness [34, 6471], macular thickness [7275], macular ganglion cell complex (GCC) thickness [7683], ganglion cell layer thickness [70, 84, 85], optic nerve head shape [30], optic nerve head volume [34, 35, 8688], optic nerve head height [7, 35], optic nerve protrusion length [89], optic disc area [90, 91], optic disc diameter [92, 93], rim area [90, 91], rim thickness [50], optic cup volume [90], retinal folds [37, 94, 95], shape of peripapillary retinal pigment epithelium-basement membrane (ppRPE/BM) layer [7, 19, 30, 36, 9698], anterior laminar cribrosa surface depth [99], posterior lamina cribrosa surface depth [99, 100], lamina cribrosa thickness [99, 100], Bruch’s membrane opening [69, 100], and pre-laminar tissue thickness (Figs. 2 and 3) [100]. The RNFL thickness was the OCT parameter most used in these studies [40, 43, 64, 66]. Most studies that compared the RNFL thickness between IIH patients and age-matched controls demonstrated that IIH patients had a significantly greater RNFL thickness compared to the controls [40, 43, 44, 51, 63, 64, 66, 101]. However, one study contradicted this trend, suggesting that control subjects had higher RNFL thickness compared to those with IIH, while another study found no significant difference in RNFL thickness between IIH patients and controls [81, 90]. In addition, it was observed that that IIH patients had initially thicker RNFL measurements, which gradually decreased over subsequent follow-up periods at 1, 3, 6, and 12 months [34, 40, 66, 67]. Among the IIH patients, those with severe papilledema were shown to have thicker RNFL than in patients with normal optic discs/minimally or moderately raised discs [41]. Patients with recurrent IIH and those without recurrence of IIH were found to have significantly different RNFL thicknesses, with the recurrence group reported to have thicker neural tissue [91]. Similarly, RNFL was greater in papilledema than in pseudopapilledema patients [54]. However, the RNFL thickness did not differ between the symptomatic and asymptomatic groups [85]. Compared to healthy controls, patients with chronic and atrophic papilledema had significantly thinner RNFL thickness [102]. In OCT imaging, ppRPE/BM is seen as a well-defined layer above the choroid in the outer retina. It is V-shaped and angled away from the vitreous in normal individuals (Fig. 4). However, in IIH patients with raised ICP, it is U-shaped and angled toward the vitreous (Fig. 5) [36, 98]. Interventions aimed at lowering the CSF pressure such as lumbar puncture and CSF shunt have demonstrated an ability to transform the ppRPE/BM layer from a U-shaped configuration to the more typical V-shaped configuration [19, 30, 36].
Few studies used a custom segmentation algorithm to develop 3D parameters such as optic nerve head volume and optic nerve head height to compare the optic nerve head changes between IIH patients and controls. They showed that the optic nerve head volume and optic nerve head height were increased in IIH patients than in controls [35, 103]. In addition, optic nerve head volume was used to differentiate between controls, treated, and untreated patients with IIH [35]. Optic disc area, diameter, rim area, thickness, and Bruch’s membrane opening were reported to be thicker in IIH patients compared to controls [69, 90]. In contrast, individuals with IIH exhibited thinner macular GCC, diminished thickness of the peripapillary choroid, reduced depth of both the anterior and posterior lamina cribrosa surfaces depths, and a decrease in optic cup volume [42, 77, 81, 90, 99]. OCT imaging was also shown to be sensitive in detecting folds such as peripapillary wrinkles, retinal and choroidal folds in patients with IIH [95].
Studies that investigated the utility of OCT in evaluating treatment outcomes in IIH patients demonstrated a significant improvement in the OCT parameters (RNFL thickness, total retinal thickness, choroidal thickness, optic nerve head volume, rim, and disc area) after interventions such as weight loss, oral acetazolamide, and optic nerve sheath fenestration [45, 86, 91]. Studies that examined the relationship between OCT measurements and clinical parameters showed a significant positive correlation between CSF pressure and various OCT parameters, including RNFL thickness, retinal thickness, macular GCC, optic nerve head volume, optic nerve head height, ppRPE/BM layer and Bruch’s membrane opening [35, 50, 51, 59, 61, 69, 86]. RNFL thickness showed significant positive correlation with visual acuity, visual field loss, papilledema severity, and the Modified Frisén Scale (MFS grades) from fundus photographs [40, 65, 77]. In addition, macular GCC thickness was found to be significantly associated with optic disc pallor [81]. However, no association was identified between CSF pressure and the shape of the optic nerve head [97].

Studies investigating OCT-A as the imaging modality in IIH

Ten studies explored the applicability of OCT-A as a non-invasive imaging biomarker for IIH. In these studies, OCT-A examinations were primarily done in acute settings of papilledema except two studies in chronic papilledema settings. Most of these studies employed OCT-A to assess the peripapillary vascular density differences between individuals with IIH and control groups. The peripapillary area is a ring-shaped zone extending from the optic disc boundary (Fig. 4) [104]. Vessel density is defined as the percentage of area occupied by both large vessels and microvasculature in a specific area and is calculated over the entire scan area, as well as in the defined sectors within the scan [105]. Capillary flux intensity is defined as the total weighted area of perfused microvascular per unit area and capillary perfusion density is defined as the total area of perfused microvasculature per unit area. The retinal vascular network is organized into four distinct plexuses: the superficial capillary plexus (SCP), intermediate capillary plexus (IP), deep capillary plexus (DCP), and radial peripapillary capillary plexus (RPC) [106]. The central retinal artery supplies blood to the SCP which then anastomoses and creates the IP and the DCP. The SCPs are located with the RNFL, ganglion cell layer, and the inner plexiform layer and the DCPs are located within the outer plexiform layer below the IP. The RCP, however, runs parallel with the nerve fiber layer axons (Fig. 5).
Several studies have investigated the peripapillary vessel density in patients with IIH in comparison to controls. Tuntas et al. found a significant reduction in peripapillary vessel density among IIH patients compared to controls in their study using the AngioVue OCT-A device, which exclusively reported peripapillary vessel density (both global and sectoral). [107] Similarly, Cakir et al., utilizing Topcon imaging, observed a notable decrease in peripapillary vessel density across different retinal capillary plexus (SCP, DCP, and choriocapillaries) in IIH patients compared to controls [108]. However, Kaya et al., also using AngioVue reported a significant elevation in peripapillary vessel density in IIH patients compared to controls, offering a contradictory perspective [109]. In contrast, Fard et al., employing AngioVue found no significant difference in peripapillary capillary density between papilledema patients and controls [110]. Moreover, microvascular densities showed an increase in the nerve fiber layer plexus (NFLP) but a reduction in the SCP and DCP in IIH patients compared to controls using the Svision imaging OCT-A device [111]. Chonsui et al.in their study using PLEX Elite device showed a decreased peripapillary capillary density without changes in capillary flux intensity in eyes with papilledema [112].
Wang et al.in their study using AngioVue device showed that NFLP positively correlated with Frisén scores of patients with IIH [111]. However, SVP, IP, and DCP inversely correlated with Frisén scores of patients with IIH. Similarly, Pahuja et al. showed a negative correlation between superficial peripapillary retinal vessel perfusion and grades of papilledema using the Angioplex device (reported superficial capillary retinal vessel perfusion, deep retinal vessel perfusion and peripapillary choriocapillary perfusion) [102]. Kwapong et al. showed microvascular densities (superficial vascular complex and deep vascular complex) positively correlated with ICP using the Svision OCT-A device [113]. Peripapillary capillary vessel density in DCP was significantly reduced in optic disc edema compared to the control group, a condition that can mimic IIH. [108]

Discussion

OCT and OCT-A are non-invasive imaging methods widely used in ophthalmology to provide high-resolution cross-sectional images of the retina [114, 115]. OCT and OCT-A measurements have also shown to be a reliable indicator of neuronal death in various neurological disorders such as Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, neuromyelitis optica, and spinocerebellar ataxia [116119]. This systematic review examined existing literature to assess the effectiveness of OCT/OCT-A as a diagnostic and monitoring modality for IIH. The predominant imaging technique in the reviewed studies was OCT, with only ten studies using OCT-A. Among studies using OCT as the imaging modality for IIH patients, the most frequently assessed parameter was RNFL thickness. Conversely, studies employing OCT-A as the imaging modality for IIH patients predominantly focused on peripapillary vessel density. In summary, studies utilizing OCT revealed increased thickness in RNFL, retina, as well as increased measurements in optic nerve head volume, optic nerve head height, optic disc diameter, rim area, and rim thickness. However, studies that used OCT-A as the imaging modality showed conflicting results regarding the peripapillary vessel density.
The RNFL comprises axons originating from retinal ganglion cells that converge from the retina and macular region to form the optic nerve. The RNFL is visualized in OCT images as the inner most retinal layer beneath the internal limiting membrane (Fig. 2). The peripapillary RNFL is measured along a 3 mm diameter circle centered on the optic nerve head and the mean thickness of the upper retinal layer is then presented as the average RNFL thickness (Fig. 6). The increased RNFL thickness reported in individuals with IIH is due to the disruption of the axonal transport and intraneural optic nerve sheath ischemia caused by the elevated CSF pressure in the subarachnoid space surrounding the optic nerve. Conversely, the reported decrease in macular GCC thickness in IIH patients is due to the loss of nerve fibers and retinal ganglion cells resulting from oxidative stress-associated prolonged swelling. The subarachnoid space connected to the optic nerve sheath undergoes structural changes due to alterations in the translaminar pressure gradient (difference between intraocular pressure and CSF pressure). Elevated ICP compresses the retrolaminar optic nerve and peripapillary scleral flange, causing deformation of the ppRPE/BM and adjacent sclera toward the vitreous [120122]. Studies in this review have shown that in IIH patients, the configuration of the ppRPE/BM follows a U-shaped pattern around the optic nerve head, transitioning to a V-shape after interventions to lower CSF levels [19].
The earliest finding of raised ICP is optic disc swelling which takes about a week or 10 days to appear. However various diagnostic methods such as MRI, serum hormonal assay, axial length evaluation, pattern electroretinogram (PERG), and visually evoked potential (VEP) tests, can aid in detecting subclinical IIH. Liu et al. demonstrated that patients experiencing pulsatile tinnitus displayed several ocular and intracranial signs of IIH on MRI scans, such as optic nerve sheath enlargement, optic nerve tortuosity, posterior globe flattening, empty Sella, downward displacement of cerebellar tonsils into the foramen magnum, and slit-like lateral ventricles [123].According to a study by Prabhat and colleagues, hormonal abnormalities such as raised prolactin, decreased TSH, and decreased cortisol were found in 37.5% of patients with IIH [124]. Moreover, studies have shown that the mean PERG and VEP amplitudes were reduced in IIH patients compared to healthy individuals [125]. Madill et al.in their study reported a significant difference in globe shape and axial length between patients with IIH and control subjects [126].
Swelling of the optic disc and increased thickness of the RNFL are not exclusive indicators of IIH or increased ICP because they can also occur in other optic neuropathies like optic neuritis and AION. Nevertheless, various parameters that describe the shape of the optic nerve head, such as, optic nerve head volume, optic nerve cup volume, central optic nerve head thickness, volume of Bruch’s membrane opening region, bending energy, minimal rim width of Bruch’s membrane opening (BMO-MRW), surface area of BMO-MRW, and area of Bruch’s membrane opening, may aid in distinguishing between different optic neuropathies. In a study by Yadav et al., a 3D model of the optic nerve head was constructed using high-resolution OCT volume scans, and it was demonstrated that all of the aforementioned parameters, except for bending energy, exhibited differences between IIH, healthy controls, and optic neuritis [127]. Similarly, Kaufhold and colleagues employed volume scans to gauge optic nerve head volume in their study, revealing that 3D parameters such as optic nerve head volume and height could distinguish between IIH patients and controls [35]. These parameters were shown to be elevated in IIH patients even when the RNFL showed normal thickness, suggesting that it could serve as a potential marker of treatment efficacy and disease advancement [35]. Future studies employing OCT as a diagnostic tool for IIH could utilize the 3D optic nerve head parameters to differentiate IIH for other optic neuropathies such as glaucoma, optic neuritis, and AION.
The central retinal artery and ophthalmic artery traverse through the subarachnoid space and are influenced by changes in ICP [128]. Out of ten studies utilizing OCT-A as an imaging modality in IIH, five revealed a decrease in peripapillary vessel density [107, 108, 111113], one demonstrated an increase in vessel density [109], and one found no disparity in vessel density between IIH patients and controls [110]. The decrease in vessel density seen in OCT-A can be due to mechanical compression of the capillary network caused by elevated ICP [129] or due to artifacts arising from the shadowing effect of fluid in papilledema artificially leading to decreased capillary density [129, 130]. Reduction in capillary vessel density has also been reported in other acute and chronic optic neuropathies such as optic neuritis, Leber’s hereditary optic neuropathy (LHON), optic atrophy and non-arteritic anterior ischemic optic neuropathy (NAION) [39]. In cases of optic neuritis and dominant optic atrophy, the decrease in vessel density may result from reduced metabolic demands caused by neuronal degeneration and the atrophy of the peripapillary RNFL and GC-IPL, which subsequently reduces blood flow through autoregulatory mechanisms [131]. However, LHON is a peripapillary microangiopathy that affects the endothelial and smooth muscle components of the blood vessel walls causing a significant reduction in the peripapillary capillary density [132]. In NAION, ischemic alterations due to dysfunctional vascular autoregulation may lead to the destruction of the capillaries [39].
The OCT parameters such as RNFL thickness, macular GCC thickness, rim area, disc area, and cup volume are easily obtained through device software (Figs. 6 and 7). However, certain parameters like optic nerve head volume, optic nerve head height, optic nerve head shape, peripapillary Bruch’s membrane angle, anterior laminar surface depth, posterior laminar surface depth, and Bruch’s membrane opening require manual calculation using custom segmentation algorithms. Most OCT devices do not automatically provide these measures, limiting their practicality in routine clinical use. In addition, accurately segmenting the outer retinal boundary in the presence of papilledema can be challenging and may lead to inaccuracies [133]. Another crucial OCT parameter for distinguishing papilledema in IIH from optic disc edema caused by other factors is the ppRPE/BM shape changes. These changes have shown a correlation with ICP [96]. However, the practical application of using ppRPE/BM changes in guiding clinical therapy is hindered by the lack of a commercial method and the need for extensive image processing to identify the RPE/BM boundary beneath an enlarged optic nerve head, limiting the integration of ppRPE/BM changes into clinical decision-making. OCT-A is relatively newer imaging methods offering both structural and blood flow information within the retina and the choroid [134]. Given that recent studies using OCT-A in IIH have produced inconsistent findings regarding peripapillary vessel density, future research should concentrate on changes in the perifoveal capillary network. This is because IIH is linked to reduced blood flow in the ophthalmic and central retinal arteries [135].
This is the first systematic review to explore studies utilizing ocular imaging as a biomarker for IIH. One of the strengths is that it included 84 studies that used either OCT or OCT-A as the imaging modality in IIH patients. In addition, this systematic review employed study quality assessment tools to appraise the quality of the included studies. There were some limitations in the study. Most of the studies included in this review were case–control studies, with only two randomized control trials. This is because most studies focused on comparing the retinal and optic nerve head changes between IIH patients and healthy controls, thus adopting a case–control design. Another limitation of the study was that it only reviewed various OCT/OCT-A parameters in IIH and could not perform a meta-analysis of these common parameters. This initial step was necessary to understand the current studies and their reporting methods, which will facilitate future meta-analyses. Moreover, conducting a meta-analysis was not possible at this stage given the following reasons: (1) the studies had significantly different designs, methods, and levels of rigor, it might be inappropriate or misleading to statistically combine their results, (2) the outcomes were reported in diverse ways, making it difficult to aggregate the results meaningfully, and (3) some studies lacked sufficient data points for a robust meta-analysis, and some were of low quality or had a high risk of bias, which could lead to misleading conclusions if combined. A narrative approach allows for a more nuanced discussion of the quality and implications of each study. Finally, the specific research question or objective of the review was thought to be better addressed through a narrative synthesis, particularly because the question is broad or exploratory in nature. Another limitation was that our review comprised just ten studies examining the utility of OCT-A in individuals with IIH. This limited number of studies may be attributed to the fact that OCT-A is a relatively recent technology, and its effectiveness in a systemic condition like IIH has yet been firmly established.
To conclude, several OCT parameters have been demonstrated to be different in IIH patients compared to controls and retinal imaging may be useful as an efficient, non-invasive, and affordable biomarker for IIH patients.

Declarations

Conflicts of interest

No potential conflict of interest was reported by the authors.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Markey KA, Mollan SP, Jensen RH, Sinclair AJ (2016) Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 15:78–91PubMed Markey KA, Mollan SP, Jensen RH, Sinclair AJ (2016) Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 15:78–91PubMed
2.
Zurück zum Zitat Kesler A, Gadoth N (2001) Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 21:12–14PubMed Kesler A, Gadoth N (2001) Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 21:12–14PubMed
3.
Zurück zum Zitat Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 18:1266–1268PubMed Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 18:1266–1268PubMed
4.
Zurück zum Zitat Durcan FJ, Corbett JJ, Wall M (1988) The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 45:875–877PubMed Durcan FJ, Corbett JJ, Wall M (1988) The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 45:875–877PubMed
5.
Zurück zum Zitat Craig JJ, Mulholland DA, Gibson JM (2001) Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991–1995). Ulster Med J 70:31–35PubMedPubMedCentral Craig JJ, Mulholland DA, Gibson JM (2001) Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991–1995). Ulster Med J 70:31–35PubMedPubMedCentral
6.
Zurück zum Zitat Friesner D, Rosenman R, Lobb BM, Tanne E (2011) Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 12:e372-380PubMed Friesner D, Rosenman R, Lobb BM, Tanne E (2011) Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 12:e372-380PubMed
7.
Zurück zum Zitat Jacobson DM, Karanjia PN, Olson KA, Warner JJ (1990) Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 40:1454–1455PubMed Jacobson DM, Karanjia PN, Olson KA, Warner JJ (1990) Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 40:1454–1455PubMed
8.
Zurück zum Zitat Bercaw BL, Greer M (1970) Transport of intrathecal 131-I risa in benign intracranial hypertension. Neurology 20:787–790PubMed Bercaw BL, Greer M (1970) Transport of intrathecal 131-I risa in benign intracranial hypertension. Neurology 20:787–790PubMed
9.
Zurück zum Zitat Riggeal BD, Bruce BB, Saindane AM, Ridha MA, Kelly LP, Newman NJ, Biousse V (2013) Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 80:289–295PubMedPubMedCentral Riggeal BD, Bruce BB, Saindane AM, Ridha MA, Kelly LP, Newman NJ, Biousse V (2013) Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 80:289–295PubMedPubMedCentral
10.
Zurück zum Zitat Giuseffi V, Wall M, Siegel PZ, Rojas PB (1991) Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case–control study. Neurology 41:239–244PubMed Giuseffi V, Wall M, Siegel PZ, Rojas PB (1991) Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case–control study. Neurology 41:239–244PubMed
11.
Zurück zum Zitat Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A):155–180PubMed Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A):155–180PubMed
12.
Zurück zum Zitat Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ (2015) Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain 16:521PubMed Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ (2015) Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain 16:521PubMed
13.
Zurück zum Zitat Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M (2015) Quality of life in idiopathic intracranial hypertension at diagnosis: IIH treatment trial results. Neurology 84:2449–2456PubMedPubMedCentral Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M (2015) Quality of life in idiopathic intracranial hypertension at diagnosis: IIH treatment trial results. Neurology 84:2449–2456PubMedPubMedCentral
14.
Zurück zum Zitat Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701PubMedPubMedCentral Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701PubMedPubMedCentral
15.
Zurück zum Zitat Sadun AA, Currie JN, Lessell S (1984) Transient visual obscurations with elevated optic discs. Ann Neurol 16:489–494PubMed Sadun AA, Currie JN, Lessell S (1984) Transient visual obscurations with elevated optic discs. Ann Neurol 16:489–494PubMed
17.
Zurück zum Zitat Biousse V, Bruce BB, Newman NJ (2012) Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 83:488–494PubMed Biousse V, Bruce BB, Newman NJ (2012) Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 83:488–494PubMed
18.
Zurück zum Zitat Smith M (2008) Monitoring intracranial pressure in traumatic brain injury. Anesth Analg 106:240–248PubMed Smith M (2008) Monitoring intracranial pressure in traumatic brain injury. Anesth Analg 106:240–248PubMed
19.
Zurück zum Zitat Sibony P, Kupersmith MJ, Honkanen R, Rohlf FJ, Torab-Parhiz A (2014) Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension. Invest Ophthalmol Vis Sci 55:8223–8231PubMedPubMedCentral Sibony P, Kupersmith MJ, Honkanen R, Rohlf FJ, Torab-Parhiz A (2014) Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension. Invest Ophthalmol Vis Sci 55:8223–8231PubMedPubMedCentral
20.
Zurück zum Zitat Saladino A, White JB, Wijdicks EF, Lanzino G (2009) Malplacement of ventricular catheters by neurosurgeons: a single institution experience. Neurocrit Care 10:248–252PubMed Saladino A, White JB, Wijdicks EF, Lanzino G (2009) Malplacement of ventricular catheters by neurosurgeons: a single institution experience. Neurocrit Care 10:248–252PubMed
21.
Zurück zum Zitat Gardner PA, Engh J, Atteberry D, Moossy JJ (2009) Hemorrhage rates after external ventricular drain placement. J Neurosurg 110:1021–1025PubMed Gardner PA, Engh J, Atteberry D, Moossy JJ (2009) Hemorrhage rates after external ventricular drain placement. J Neurosurg 110:1021–1025PubMed
22.
Zurück zum Zitat Raboel PH, Bartek J Jr, Andresen M, Bellander BM, Romner B (2012) Intracranial pressure monitoring: invasive versus non-invasive methods-a review. Crit Care Res Pract 2012:950393PubMedPubMedCentral Raboel PH, Bartek J Jr, Andresen M, Bellander BM, Romner B (2012) Intracranial pressure monitoring: invasive versus non-invasive methods-a review. Crit Care Res Pract 2012:950393PubMedPubMedCentral
23.
Zurück zum Zitat Tran K, Pakzad-Vaezi K (2018) Multimodal imaging of diabetic retinopathy. Curr Opin Ophthalmol 29:566–575PubMed Tran K, Pakzad-Vaezi K (2018) Multimodal imaging of diabetic retinopathy. Curr Opin Ophthalmol 29:566–575PubMed
24.
Zurück zum Zitat Le P, Zehden J, Zhang AY (2021) Role of optical coherence tomography angiography imaging in patients with diabetes. Curr Diab Rep 21:42PubMed Le P, Zehden J, Zhang AY (2021) Role of optical coherence tomography angiography imaging in patients with diabetes. Curr Diab Rep 21:42PubMed
25.
Zurück zum Zitat Schimel AM, Fisher YL, Flynn HW Jr (2011) Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain. Ophthal Surg Lasers Imaging 42(Suppl):S41-55 Schimel AM, Fisher YL, Flynn HW Jr (2011) Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain. Ophthal Surg Lasers Imaging 42(Suppl):S41-55
26.
Zurück zum Zitat Regatieri CV, Branchini L, Duker JS (2011) The role of spectral-domain OCT in the diagnosis and management of neovascular age-related macular degeneration. Ophthal Surg Lasers Imaging 42(Suppl):S56-66 Regatieri CV, Branchini L, Duker JS (2011) The role of spectral-domain OCT in the diagnosis and management of neovascular age-related macular degeneration. Ophthal Surg Lasers Imaging 42(Suppl):S56-66
27.
Zurück zum Zitat Talks SJ, Aftab AM, Ashfaq I, Soomro T (2017) The role of new imaging methods in managing age-related macular degeneration. Asia Pac J Ophthalmol (Phil) 6:498–507 Talks SJ, Aftab AM, Ashfaq I, Soomro T (2017) The role of new imaging methods in managing age-related macular degeneration. Asia Pac J Ophthalmol (Phil) 6:498–507
28.
Zurück zum Zitat Hirano Y, Suzuki N, Tomiyasu T, Kurobe R, Yasuda Y, Esaki Y, Yasukawa T, Yoshida M, Ogura Y (2021) Multimodal imaging of microvascular abnormalities in retinal vein occlusion. J Clin Med 10:405PubMedPubMedCentral Hirano Y, Suzuki N, Tomiyasu T, Kurobe R, Yasuda Y, Esaki Y, Yasukawa T, Yoshida M, Ogura Y (2021) Multimodal imaging of microvascular abnormalities in retinal vein occlusion. J Clin Med 10:405PubMedPubMedCentral
29.
Zurück zum Zitat Coffey AM, Hutton EK, Combe L, Bhindi P, Gertig D, Constable PA (2021) Optical coherence tomography angiography in primary eye care. Clin Exp Optom 104:3–13PubMed Coffey AM, Hutton EK, Combe L, Bhindi P, Gertig D, Constable PA (2021) Optical coherence tomography angiography in primary eye care. Clin Exp Optom 104:3–13PubMed
30.
Zurück zum Zitat Wang JK, Kardon RH, Ledolter J, Sibony PA, Kupersmith MJ, Garvin MK (2017) Peripapillary retinal pigment epithelium layer shape changes from acetazolamide treatment in the idiopathic intracranial hypertension treatment trial. Invest Ophthalmol Vis Sci 58(5):2554–2565PubMedPubMedCentral Wang JK, Kardon RH, Ledolter J, Sibony PA, Kupersmith MJ, Garvin MK (2017) Peripapillary retinal pigment epithelium layer shape changes from acetazolamide treatment in the idiopathic intracranial hypertension treatment trial. Invest Ophthalmol Vis Sci 58(5):2554–2565PubMedPubMedCentral
31.
Zurück zum Zitat Anand A, Pass A, Urfy MZ, Tang R, Cajavilca C, Calvillo E, Suarez JI, Venkatasubba Rao CP, Bershad EM (2016) Optical coherence tomography of the optic nerve head detects acute changes in intracranial pressure. J Clin Neurosci 29:73–76PubMed Anand A, Pass A, Urfy MZ, Tang R, Cajavilca C, Calvillo E, Suarez JI, Venkatasubba Rao CP, Bershad EM (2016) Optical coherence tomography of the optic nerve head detects acute changes in intracranial pressure. J Clin Neurosci 29:73–76PubMed
32.
Zurück zum Zitat Sarac O, Tasci YY, Gurdal C, Can I (2012) Differentiation of optic disc edema from optic nerve head drusen with spectral-domain optical coherence tomography. J Neuroophthalmol 32:207–211PubMed Sarac O, Tasci YY, Gurdal C, Can I (2012) Differentiation of optic disc edema from optic nerve head drusen with spectral-domain optical coherence tomography. J Neuroophthalmol 32:207–211PubMed
33.
Zurück zum Zitat Carta A, Mora P, Aldigeri R, Gozzi F, Favilla S, Tedesco S, Calzetti G, Farci R, Barboni P, Bianchi-Marzoli S, Fossarello M, Gandolfi S, Sadun AA (2018) Optical coherence tomography is a useful tool in the differentiation between true edema and pseudoedema of the optic disc. PLoS ONE 13:e0208145PubMedPubMedCentral Carta A, Mora P, Aldigeri R, Gozzi F, Favilla S, Tedesco S, Calzetti G, Farci R, Barboni P, Bianchi-Marzoli S, Fossarello M, Gandolfi S, Sadun AA (2018) Optical coherence tomography is a useful tool in the differentiation between true edema and pseudoedema of the optic disc. PLoS ONE 13:e0208145PubMedPubMedCentral
34.
Zurück zum Zitat Auinger P et al (2015) Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial. Ophthalmology 122:1939-1945.e1932 Auinger P et al (2015) Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial. Ophthalmology 122:1939-1945.e1932
35.
Zurück zum Zitat Kaufhold F, Kadas EM, Schmidt C, Kunte H, Hoffmann J, Zimmermann H, Oberwahrenbrock T, Harms L, Polthier K, Brandt AU, Paul F (2012) Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS ONE 7:e36965PubMedPubMedCentral Kaufhold F, Kadas EM, Schmidt C, Kunte H, Hoffmann J, Zimmermann H, Oberwahrenbrock T, Harms L, Polthier K, Brandt AU, Paul F (2012) Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS ONE 7:e36965PubMedPubMedCentral
36.
Zurück zum Zitat Sibony P, Kupersmith MJ, Rohlf FJ (2011) Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy. Invest Ophthalmol Vis Sci 52:7987–7995PubMedPubMedCentral Sibony P, Kupersmith MJ, Rohlf FJ (2011) Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy. Invest Ophthalmol Vis Sci 52:7987–7995PubMedPubMedCentral
37.
Zurück zum Zitat Kupersmith MJ, Sibony PA, Feldon SE, Wang JK, Garvin M, Kardon R (2017) The effect of treatment of idiopathic intracranial hypertension on prevalence of retinal and choroidal folds. Am J Ophthalmol 176:77–86PubMed Kupersmith MJ, Sibony PA, Feldon SE, Wang JK, Garvin M, Kardon R (2017) The effect of treatment of idiopathic intracranial hypertension on prevalence of retinal and choroidal folds. Am J Ophthalmol 176:77–86PubMed
38.
Zurück zum Zitat Sibony PA, Kupersmith MJ (2016) “Paton’s folds” revisited: peripapillary wrinkles, folds, and creases in papilledema. Ophthalmology 123:1397–1399PubMed Sibony PA, Kupersmith MJ (2016) “Paton’s folds” revisited: peripapillary wrinkles, folds, and creases in papilledema. Ophthalmology 123:1397–1399PubMed
39.
Zurück zum Zitat Ghasemi Falavarjani K, Tian JJ, Akil H, Garcia GA, Sadda SR, Sadun AA (2016) Swept-source optical coherence tomography angiography of the optic disk in optic neuropathy. Retina 36(Suppl 1):S168-s177PubMed Ghasemi Falavarjani K, Tian JJ, Akil H, Garcia GA, Sadda SR, Sadun AA (2016) Swept-source optical coherence tomography angiography of the optic disk in optic neuropathy. Retina 36(Suppl 1):S168-s177PubMed
40.
Zurück zum Zitat Rebolleda G, Munoz-Negrete FJ (2009) Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci 50:5197–5200PubMed Rebolleda G, Munoz-Negrete FJ (2009) Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci 50:5197–5200PubMed
41.
Zurück zum Zitat Waisbourd M, Leibovitch I, Goldenberg D, Kesler A (2011) OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg 113:839–843PubMed Waisbourd M, Leibovitch I, Goldenberg D, Kesler A (2011) OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg 113:839–843PubMed
42.
Zurück zum Zitat Marzoli SB, Ciasca P, Curone M, Cammarata G, Melzi L, Criscuoli A, Bussone G, D’Amico D (2013) Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis. Neurol Sci 34(Suppl 1):S143-145PubMed Marzoli SB, Ciasca P, Curone M, Cammarata G, Melzi L, Criscuoli A, Bussone G, D’Amico D (2013) Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis. Neurol Sci 34(Suppl 1):S143-145PubMed
43.
Zurück zum Zitat Skau M, Yri H, Sander B, Gerds TA, Milea D, Jensen R (2013) Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 251:567–574PubMed Skau M, Yri H, Sander B, Gerds TA, Milea D, Jensen R (2013) Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 251:567–574PubMed
44.
Zurück zum Zitat Fard MA, Fakhree S, Abdi P, Hassanpoor N, Subramanian PS (2014) Quantification of peripapillary total retinal volume in pseudopapilledema and mild papilledema using spectral-domain optical coherence tomography. Am J Ophthalmol 158:136–143PubMed Fard MA, Fakhree S, Abdi P, Hassanpoor N, Subramanian PS (2014) Quantification of peripapillary total retinal volume in pseudopapilledema and mild papilledema using spectral-domain optical coherence tomography. Am J Ophthalmol 158:136–143PubMed
45.
Zurück zum Zitat Starks V, Gilliland G, Vrcek I, Gilliland C (2016) Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness. Orbit 35:87–90PubMed Starks V, Gilliland G, Vrcek I, Gilliland C (2016) Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness. Orbit 35:87–90PubMed
46.
Zurück zum Zitat Dinkin MJ, Patsalides A (2017) Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol 37:113–121PubMed Dinkin MJ, Patsalides A (2017) Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol 37:113–121PubMed
47.
Zurück zum Zitat Saenz R, Cheng H, Prager TC, Frishman LJ, Tang RA (2017) Use of A-scan ultrasound and optical coherence tomography to differentiate papilledema from pseudopapilledema. Optom Vis Sci 94:1081–1089PubMedPubMedCentral Saenz R, Cheng H, Prager TC, Frishman LJ, Tang RA (2017) Use of A-scan ultrasound and optical coherence tomography to differentiate papilledema from pseudopapilledema. Optom Vis Sci 94:1081–1089PubMedPubMedCentral
48.
Zurück zum Zitat Aojula A, Mollan SP, Horsburgh J, Yiangou A, Markey KA, Mitchell JL, Scotton WJ, Keane PA, Sinclair AJ (2018) Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension. BMC Ophthalmol 17:257PubMedPubMedCentral Aojula A, Mollan SP, Horsburgh J, Yiangou A, Markey KA, Mitchell JL, Scotton WJ, Keane PA, Sinclair AJ (2018) Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension. BMC Ophthalmol 17:257PubMedPubMedCentral
49.
Zurück zum Zitat Huang-Link Y, Eleftheriou A, Yang G, Johansson JM, Apostolou A, Link H, Jin YP (2019) Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema. Eur J Neurol 26:808-e857PubMed Huang-Link Y, Eleftheriou A, Yang G, Johansson JM, Apostolou A, Link H, Jin YP (2019) Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema. Eur J Neurol 26:808-e857PubMed
50.
Zurück zum Zitat Onder H, Erkan E (2019) The association of optical coherence tomography results with neuroimaging signs and some clinical parameters in idiopathic intracranial hypertension. J Neurol Res 9:65–71 Onder H, Erkan E (2019) The association of optical coherence tomography results with neuroimaging signs and some clinical parameters in idiopathic intracranial hypertension. J Neurol Res 9:65–71
51.
Zurück zum Zitat Merticariu CI, Balta F, Merticariu A, Ciuluvica R, Voinea L (2019) Optical coherence tomography assessment of structural changes in the optic nerve head and peripapillary retina in idiopathic intracranial hypertension. Arch Balk Med Union 54:267–273 Merticariu CI, Balta F, Merticariu A, Ciuluvica R, Voinea L (2019) Optical coherence tomography assessment of structural changes in the optic nerve head and peripapillary retina in idiopathic intracranial hypertension. Arch Balk Med Union 54:267–273
52.
Zurück zum Zitat Wall M, Subramani A, Chong LX, Galindo R, Turpin A, Kardon RH, Thurtell MJ, Bailey JA, Marin-Franch I (2019) Threshold static automated perimetry of the full visual field in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 60:1898–1905PubMed Wall M, Subramani A, Chong LX, Galindo R, Turpin A, Kardon RH, Thurtell MJ, Bailey JA, Marin-Franch I (2019) Threshold static automated perimetry of the full visual field in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 60:1898–1905PubMed
53.
Zurück zum Zitat Bahnasy WS, El-Heneedy YAE, Elhassanien MEM, Sharaf AF, Khalid HA (2019) Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension. Egypt J Neurol Psychiatry Neurosurg 55:26 Bahnasy WS, El-Heneedy YAE, Elhassanien MEM, Sharaf AF, Khalid HA (2019) Neuro-ophthalmological biomarkers of visual outcome in newly diagnosed idiopathic intracranial hypertension. Egypt J Neurol Psychiatry Neurosurg 55:26
54.
Zurück zum Zitat Flowers AM, Longmuir RA, Liu Y, Chen Q, Donahue SP (2021) Variability within optic nerve optical coherence tomography measurements distinguishes papilledema from pseudopapilledema. J Neuroophthalmol 41(4):496–503PubMed Flowers AM, Longmuir RA, Liu Y, Chen Q, Donahue SP (2021) Variability within optic nerve optical coherence tomography measurements distinguishes papilledema from pseudopapilledema. J Neuroophthalmol 41(4):496–503PubMed
55.
Zurück zum Zitat Carey AR, Bosley TM, Miller NR, McCulley TJ, Henderson AD (2021) Use of en face optical coherence tomography to monitor papilledema in idiopathic intracranial hypertension: a pilot study. J Neuroophthalmol 41:212–216PubMed Carey AR, Bosley TM, Miller NR, McCulley TJ, Henderson AD (2021) Use of en face optical coherence tomography to monitor papilledema in idiopathic intracranial hypertension: a pilot study. J Neuroophthalmol 41:212–216PubMed
56.
Zurück zum Zitat Kohli AA, Pistilli M, Alfaro C, Ross AG, Jivraj I, Bagchi S, Chan J, May D, Liu GT, Shindler KS, Tamhankar MA (2021) Role of ocular ultrasonography to distinguish papilledema from pseudopapilledema. J Neuroophthalmol 41:206–211PubMed Kohli AA, Pistilli M, Alfaro C, Ross AG, Jivraj I, Bagchi S, Chan J, May D, Liu GT, Shindler KS, Tamhankar MA (2021) Role of ocular ultrasonography to distinguish papilledema from pseudopapilledema. J Neuroophthalmol 41:206–211PubMed
57.
Zurück zum Zitat Inam ME, Martinez-Gutierrez JC, Kole MJ, Sanchez F, Lekka E, Truong VTT, Lopez-Rivera V, Sheriff FG, Zima LA, Pedroza C, Tang R, Adesina OO, Engstrom A, Sheth SA, Chen PR (2022) Venous sinus stenting for low pressure gradient stenoses in idiopathic intracranial hypertension. Neurosurgery 91:734–740PubMedPubMedCentral Inam ME, Martinez-Gutierrez JC, Kole MJ, Sanchez F, Lekka E, Truong VTT, Lopez-Rivera V, Sheriff FG, Zima LA, Pedroza C, Tang R, Adesina OO, Engstrom A, Sheth SA, Chen PR (2022) Venous sinus stenting for low pressure gradient stenoses in idiopathic intracranial hypertension. Neurosurgery 91:734–740PubMedPubMedCentral
58.
Zurück zum Zitat Thaller M, Tsermoulas G, Sun R, Mollan SP, Sinclair AJ (2021) Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 92:795–797PubMed Thaller M, Tsermoulas G, Sun R, Mollan SP, Sinclair AJ (2021) Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 92:795–797PubMed
59.
Zurück zum Zitat Sood G, Samanta R, Kumawat D, Agrawal A, Singh A (2022) Clinical profile and retinal nerve fibre layer thickness of optic disc oedema patients at a tertiary care institute in North India. Therapy 14:25158414211072630 Sood G, Samanta R, Kumawat D, Agrawal A, Singh A (2022) Clinical profile and retinal nerve fibre layer thickness of optic disc oedema patients at a tertiary care institute in North India. Therapy 14:25158414211072630
60.
Zurück zum Zitat Vosoughi AR, Margolin EA, Micieli JA (2022) Idiopathic intracranial hypertension: incidental discovery versus symptomatic presentation. J Neuroophthalmol 42:187–191PubMed Vosoughi AR, Margolin EA, Micieli JA (2022) Idiopathic intracranial hypertension: incidental discovery versus symptomatic presentation. J Neuroophthalmol 42:187–191PubMed
61.
Zurück zum Zitat Kaya Tutar N, Kale N (2023) The relationship between lumbar puncture opening pressure and retinal nerve fiber layer thickness in the diagnosis of idiopathic intracranial hypertension: is a lumbar puncture always necessary? Neurolog 25:25 Kaya Tutar N, Kale N (2023) The relationship between lumbar puncture opening pressure and retinal nerve fiber layer thickness in the diagnosis of idiopathic intracranial hypertension: is a lumbar puncture always necessary? Neurolog 25:25
62.
Zurück zum Zitat Xie JS, Donaldson L, Margolin EA (2023) Swelling of atrophic optic discs in idiopathic intracranial hypertension. J Neuroophthalmol 44(2):212–218PubMed Xie JS, Donaldson L, Margolin EA (2023) Swelling of atrophic optic discs in idiopathic intracranial hypertension. J Neuroophthalmol 44(2):212–218PubMed
63.
Zurück zum Zitat Srija YN, Pattnaik L, Mishra S, Panigrahi PK (2024) An optical coherence study on optic disc parameters and peripapillary retinal nerve fiber layer thickness in patients with optic disc edema. Indian J Ophthalmol 72:S96–S100PubMed Srija YN, Pattnaik L, Mishra S, Panigrahi PK (2024) An optical coherence study on optic disc parameters and peripapillary retinal nerve fiber layer thickness in patients with optic disc edema. Indian J Ophthalmol 72:S96–S100PubMed
64.
Zurück zum Zitat Jensen R, Skau M (2010) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Headache Pain 1:S71 Jensen R, Skau M (2010) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Headache Pain 1:S71
65.
Zurück zum Zitat Scott CJ, Kardon RH, Lee AG, Frisen L, Wall M (2010) Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128:705–711PubMed Scott CJ, Kardon RH, Lee AG, Frisen L, Wall M (2010) Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128:705–711PubMed
66.
Zurück zum Zitat Skau M, Sander B, Milea D, Jensen R (2011) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol 258:277PubMed Skau M, Sander B, Milea D, Jensen R (2011) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol 258:277PubMed
67.
Zurück zum Zitat Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case–control study. Cephalalgia 35:553–562PubMed Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case–control study. Cephalalgia 35:553–562PubMed
68.
Zurück zum Zitat Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci 55:8180–8188PubMed Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci 55:8180–8188PubMed
69.
Zurück zum Zitat Bingol Kiziltunc P, Atilla H (2021) A novel biomarker for increased intracranial pressure in idiopathic intracranial hypertension. Jpn J Ophthalmol 65(3):416–422PubMed Bingol Kiziltunc P, Atilla H (2021) A novel biomarker for increased intracranial pressure in idiopathic intracranial hypertension. Jpn J Ophthalmol 65(3):416–422PubMed
70.
Zurück zum Zitat Attia R, Fitoussi R, Mairot K, Demortiere S, Stellman JP, Tilsley P, Audoin B, David T, Stolowy N (2023) Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients. BMJ Open Ophthalmol 8:e001375PubMedPubMedCentral Attia R, Fitoussi R, Mairot K, Demortiere S, Stellman JP, Tilsley P, Audoin B, David T, Stolowy N (2023) Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients. BMJ Open Ophthalmol 8:e001375PubMedPubMedCentral
71.
Zurück zum Zitat Wang JR, Linton EF, Johnson BA, Kupersmith MJ, Garvin MK, Kardon RH (2024) Visualization of optic nerve structural patterns in papilledema using deep learning variational autoencoders. Transl Vis Sci Technol 13:13PubMedPubMedCentral Wang JR, Linton EF, Johnson BA, Kupersmith MJ, Garvin MK, Kardon RH (2024) Visualization of optic nerve structural patterns in papilledema using deep learning variational autoencoders. Transl Vis Sci Technol 13:13PubMedPubMedCentral
72.
Zurück zum Zitat Monteiro ML, Afonso CL (2014) Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye 28:390–398PubMedPubMedCentral Monteiro ML, Afonso CL (2014) Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome. Eye 28:390–398PubMedPubMedCentral
73.
Zurück zum Zitat Goldhagen BE, Bhatti MT, Srinivasan PP, Chiu SJ, Farsiu S, El-Dairi MA (2015) Retinal atrophy in eyes with resolved papilledema detected by optical coherence tomography. J Neuroophthalmol 35:122–126PubMed Goldhagen BE, Bhatti MT, Srinivasan PP, Chiu SJ, Farsiu S, El-Dairi MA (2015) Retinal atrophy in eyes with resolved papilledema detected by optical coherence tomography. J Neuroophthalmol 35:122–126PubMed
74.
Zurück zum Zitat Kabatas N, Eren Y, Nalcacioglu P, Caliskan S, Bicer T, Comoglu SS, Gurdal C (2021) Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients. Int Ophthalmol 41:1467–1477PubMed Kabatas N, Eren Y, Nalcacioglu P, Caliskan S, Bicer T, Comoglu SS, Gurdal C (2021) Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients. Int Ophthalmol 41:1467–1477PubMed
75.
Zurück zum Zitat Rehman O, Ichhpujani P, Singla E, Negi R, Kumar S (2022) Change in contrast sensitivity and OCT parameters in idiopathic intracranial hypertension. Ther Adv Ophthalmol 14:25158414221083360PubMedPubMedCentral Rehman O, Ichhpujani P, Singla E, Negi R, Kumar S (2022) Change in contrast sensitivity and OCT parameters in idiopathic intracranial hypertension. Ther Adv Ophthalmol 14:25158414221083360PubMedPubMedCentral
76.
Zurück zum Zitat Chen JJ, Thurtell MJ, Longmuir RA, Garvin MK, Wang JK, Wall M, Kardon RH (2015) Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56:3850–3859PubMedPubMedCentral Chen JJ, Thurtell MJ, Longmuir RA, Garvin MK, Wang JK, Wall M, Kardon RH (2015) Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56:3850–3859PubMedPubMedCentral
77.
Zurück zum Zitat Labib D, Abdel Raouf D (2015) Diagnostic value of optical coherence tomography in patients with idiopathic intracranial hypertension. Egypt J Neurol Psychiatry Neurosurg 52:249 Labib D, Abdel Raouf D (2015) Diagnostic value of optical coherence tomography in patients with idiopathic intracranial hypertension. Egypt J Neurol Psychiatry Neurosurg 52:249
78.
Zurück zum Zitat Moss HE, Park JC, McAnany JJ (2015) The photopic negative response in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56:3709–3714PubMedPubMedCentral Moss HE, Park JC, McAnany JJ (2015) The photopic negative response in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56:3709–3714PubMedPubMedCentral
79.
Zurück zum Zitat Park JC, Moss HE, McAnany JJ (2018) Electroretinography in idiopathic intracranial hypertension: comparison of the pattern ERG and the photopic negative response. Doc Ophthalmol 136:45–55PubMed Park JC, Moss HE, McAnany JJ (2018) Electroretinography in idiopathic intracranial hypertension: comparison of the pattern ERG and the photopic negative response. Doc Ophthalmol 136:45–55PubMed
80.
Zurück zum Zitat Chen Q, Feng C, Zhao G, Chen W, Wang M, Sun X, Sha Y, Li Z, Tian G (2020) Pseudotumour cerebri syndrome in China: a cohort study. Sci Rep 10:1222PubMedPubMedCentral Chen Q, Feng C, Zhao G, Chen W, Wang M, Sun X, Sha Y, Li Z, Tian G (2020) Pseudotumour cerebri syndrome in China: a cohort study. Sci Rep 10:1222PubMedPubMedCentral
81.
Zurück zum Zitat Nogueira PF, Caiado GC, Gracitelli CPB, Martins FM, Barros FCD, Matas SLA, Teixeira SH, Noia LDC, Paulo DA (2021) Association between optical coherence tomography measurements and clinical parameters in idiopathic intracranial hypertension. J Ophthalmol 2021:1401609PubMedPubMedCentral Nogueira PF, Caiado GC, Gracitelli CPB, Martins FM, Barros FCD, Matas SLA, Teixeira SH, Noia LDC, Paulo DA (2021) Association between optical coherence tomography measurements and clinical parameters in idiopathic intracranial hypertension. J Ophthalmol 2021:1401609PubMedPubMedCentral
82.
Zurück zum Zitat Wibroe EA, Malmqvist L, Hamann S (2021) OCT based interpretation of the optic nerve head anatomy and prevalence of optic disc drusen in patients with idiopathic intracranial hypertension (IIH). Life (Basel) 11:584PubMed Wibroe EA, Malmqvist L, Hamann S (2021) OCT based interpretation of the optic nerve head anatomy and prevalence of optic disc drusen in patients with idiopathic intracranial hypertension (IIH). Life (Basel) 11:584PubMed
83.
Zurück zum Zitat Bassi ST, Pamu R, Ambika S, Praveen S, Priyadarshini D, Dharini V, Padmalakshmi K (2024) Optical coherence tomography in papilledema: a probe into the intracranial pressure correlation. Indian J Ophthalmol 62:1146–1151 Bassi ST, Pamu R, Ambika S, Praveen S, Priyadarshini D, Dharini V, Padmalakshmi K (2024) Optical coherence tomography in papilledema: a probe into the intracranial pressure correlation. Indian J Ophthalmol 62:1146–1151
84.
Zurück zum Zitat Touzé R, Bonnin S, Houdart E, Nicholson P, Bodaghi B, Shotar E, Clarençon F, Lenck S, Touitou V (2021) Long-term kinetic papilledema improvement after venous sinus stenting in idiopathic intracranial hypertension. Clin Neuroradiol 31:483–490PubMed Touzé R, Bonnin S, Houdart E, Nicholson P, Bodaghi B, Shotar E, Clarençon F, Lenck S, Touitou V (2021) Long-term kinetic papilledema improvement after venous sinus stenting in idiopathic intracranial hypertension. Clin Neuroradiol 31:483–490PubMed
85.
Zurück zum Zitat Thaller M, Homer V, Mollan SP, Sinclair AJ (2023) Asymptomatic idiopathic intracranial hypertension: prevalence and prognosis. Clin Exp Ophthalmol 51:598–606PubMedPubMedCentral Thaller M, Homer V, Mollan SP, Sinclair AJ (2023) Asymptomatic idiopathic intracranial hypertension: prevalence and prognosis. Clin Exp Ophthalmol 51:598–606PubMedPubMedCentral
86.
Zurück zum Zitat Albrecht P, Blasberg C, Ringelstein M, Müller AK, Finis D, Guthoff R, Kadas EM, Lagreze W, Aktas O, Hartung HP, Paul F, Brandt AU, Methner A (2017) Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol 264:1370–1380PubMed Albrecht P, Blasberg C, Ringelstein M, Müller AK, Finis D, Guthoff R, Kadas EM, Lagreze W, Aktas O, Hartung HP, Paul F, Brandt AU, Methner A (2017) Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol 264:1370–1380PubMed
87.
Zurück zum Zitat Sheils CR, Fischer WS, Hollar RA, Blanchard LM, Feldon SE (2018) The relationship between optic disc volume, area, and Frisén score in patients with idiopathic intracranial hypertension. Am J Ophthalmol 195:101–109PubMedPubMedCentral Sheils CR, Fischer WS, Hollar RA, Blanchard LM, Feldon SE (2018) The relationship between optic disc volume, area, and Frisén score in patients with idiopathic intracranial hypertension. Am J Ophthalmol 195:101–109PubMedPubMedCentral
88.
Zurück zum Zitat Vijay V, Mollan SP, Mitchell JL, Bilton E, Alimajstorovic Z, Markey KA, Fong A, Walker JK, Lyons HS, Yiangou A, Tsermoulas G, Brock K, Sinclair AJ (2020) Using optical coherence tomography as a surrogate of measurements of intracranial pressure in idiopathic intracranial hypertension. JAMA Ophthalmol 138:1264–1271PubMed Vijay V, Mollan SP, Mitchell JL, Bilton E, Alimajstorovic Z, Markey KA, Fong A, Walker JK, Lyons HS, Yiangou A, Tsermoulas G, Brock K, Sinclair AJ (2020) Using optical coherence tomography as a surrogate of measurements of intracranial pressure in idiopathic intracranial hypertension. JAMA Ophthalmol 138:1264–1271PubMed
89.
Zurück zum Zitat Chang YC, Alperin N, Bagci AM, Lee SH, Rosa PR, Giovanni G, Lam BL (2015) Relationship between optic nerve protrusion measured by OCT and MRI and papilledema severity. Invest Ophthalmol Vis Sci 56:2297–2302PubMed Chang YC, Alperin N, Bagci AM, Lee SH, Rosa PR, Giovanni G, Lam BL (2015) Relationship between optic nerve protrusion measured by OCT and MRI and papilledema severity. Invest Ophthalmol Vis Sci 56:2297–2302PubMed
90.
Zurück zum Zitat Eren Y, Kabatas N, Guven H, Comoglu S, Gurdal C (2019) Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension. Acta Neurol Belg 119:351–357PubMed Eren Y, Kabatas N, Guven H, Comoglu S, Gurdal C (2019) Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension. Acta Neurol Belg 119:351–357PubMed
91.
Zurück zum Zitat Rehman O, Ichhpujani P, Kumar S, Saroa R, Sawal N (2022) Idiopathic intracranial hypertension and visual function in North Indian population. Eur J Ophthalmol 32(2):1186–1193 Rehman O, Ichhpujani P, Kumar S, Saroa R, Sawal N (2022) Idiopathic intracranial hypertension and visual function in North Indian population. Eur J Ophthalmol 32(2):1186–1193
92.
Zurück zum Zitat Kaya FS, Arici C (2023) Assessment of peripapillary choroidal thicknesses and optic disc diameters in idiopathic intracranial hypertension. Can J Ophthalmol 58:212–218PubMed Kaya FS, Arici C (2023) Assessment of peripapillary choroidal thicknesses and optic disc diameters in idiopathic intracranial hypertension. Can J Ophthalmol 58:212–218PubMed
93.
Zurück zum Zitat Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701PubMedPubMedCentral Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701PubMedPubMedCentral
94.
Zurück zum Zitat Sibony PA, Kupersmith MJ, Feldon SE, Wang JK, Garvin M, Auinger P, Durbin M, Garvin MK, Kardon RH, Keltner J, Wang JK, Kupersmith M, Cello K, Werner JS (2015) Retinal and choroidal folds in papilledema. Invest Ophthalmol Vis Sci 56:5670–5680PubMedPubMedCentral Sibony PA, Kupersmith MJ, Feldon SE, Wang JK, Garvin M, Auinger P, Durbin M, Garvin MK, Kardon RH, Keltner J, Wang JK, Kupersmith M, Cello K, Werner JS (2015) Retinal and choroidal folds in papilledema. Invest Ophthalmol Vis Sci 56:5670–5680PubMedPubMedCentral
95.
Zurück zum Zitat Reggie SN, Avery RA, Bavinger JC, Jivraj I, Alfaro C, Pistilli M, Kohli AA, Liu GT, Shindler KS, Ross AG, Kardon RH, Sibony PA, Tamhankar M (2021) The sensitivity and specificity of retinal and choroidal folds to distinguish between mild papilloedema and pseudopapilledema. Eye (Basingstoke) 35(11):3131–3136 Reggie SN, Avery RA, Bavinger JC, Jivraj I, Alfaro C, Pistilli M, Kohli AA, Liu GT, Shindler KS, Ross AG, Kardon RH, Sibony PA, Tamhankar M (2021) The sensitivity and specificity of retinal and choroidal folds to distinguish between mild papilloedema and pseudopapilledema. Eye (Basingstoke) 35(11):3131–3136
96.
Zurück zum Zitat Gampa A, Vangipuram G, Shirazi Z, Moss HE (2017) Quantitative association between peripapillary Bruch’s membrane shape and intracranial pressure. Invest Ophthalmol Vis Sci 58:2739–2745PubMedPubMedCentral Gampa A, Vangipuram G, Shirazi Z, Moss HE (2017) Quantitative association between peripapillary Bruch’s membrane shape and intracranial pressure. Invest Ophthalmol Vis Sci 58:2739–2745PubMedPubMedCentral
97.
Zurück zum Zitat Banik R, Kupersmith MJ, Wang JK, Garvin MK (2019) The effect of acetazolamide and weight loss on intraocular pressure in idiopathic intracranial hypertension patients. J Glaucoma 28:352–356PubMed Banik R, Kupersmith MJ, Wang JK, Garvin MK (2019) The effect of acetazolamide and weight loss on intraocular pressure in idiopathic intracranial hypertension patients. J Glaucoma 28:352–356PubMed
98.
Zurück zum Zitat Panyala R, Sharma P, Sihota R, Saxena R, Prasad K, Phuljhele S, Gurrala S, Bhaskaran K (2021) Role of spectral domain optical coherence tomography in the diagnosis and prognosis of papilledema. Indian J Ophthalmol 69:2372–2377PubMedPubMedCentral Panyala R, Sharma P, Sihota R, Saxena R, Prasad K, Phuljhele S, Gurrala S, Bhaskaran K (2021) Role of spectral domain optical coherence tomography in the diagnosis and prognosis of papilledema. Indian J Ophthalmol 69:2372–2377PubMedPubMedCentral
99.
Zurück zum Zitat Pasaoglu I, Satana B, Altan C, Artunay O, Basarir B, Onmez FE, Inal A (2019) Lamina cribrosa surface position in idiopathic intracranial hypertension with swept-source optical coherence tomography. Indian J Ophthalmol 67:1085–1088PubMedPubMedCentral Pasaoglu I, Satana B, Altan C, Artunay O, Basarir B, Onmez FE, Inal A (2019) Lamina cribrosa surface position in idiopathic intracranial hypertension with swept-source optical coherence tomography. Indian J Ophthalmol 67:1085–1088PubMedPubMedCentral
100.
Zurück zum Zitat Tatar IT, Solmaz B, Erdem ZG, Pasaoglu I, Demircan A, Tülü Aygün B, Ozkaya A (2020) Morphological assessment of lamina cribrosa in idiopathic intracranial hypertension. Indian J Ophthalmol 68:164–167PubMed Tatar IT, Solmaz B, Erdem ZG, Pasaoglu I, Demircan A, Tülü Aygün B, Ozkaya A (2020) Morphological assessment of lamina cribrosa in idiopathic intracranial hypertension. Indian J Ophthalmol 68:164–167PubMed
101.
Zurück zum Zitat Ozdemir I, Çevik S (2020) Measurement of choroid thickness using optical coherence tomography to monitor intracranial pressure in an idiopathic cranial hypertension model. Neurol India 68:636–639PubMed Ozdemir I, Çevik S (2020) Measurement of choroid thickness using optical coherence tomography to monitor intracranial pressure in an idiopathic cranial hypertension model. Neurol India 68:636–639PubMed
102.
Zurück zum Zitat Pahuja A, Dhiman R, Aggarwal V, Aalok SP, Saxena R (2024) Evaluation of peripapillary and macular optical coherence tomography angiography characteristics in different stages of papilledema. J Neuroophthalmol 44:53–60PubMed Pahuja A, Dhiman R, Aggarwal V, Aalok SP, Saxena R (2024) Evaluation of peripapillary and macular optical coherence tomography angiography characteristics in different stages of papilledema. J Neuroophthalmol 44:53–60PubMed
103.
Zurück zum Zitat Dreesbach M, Joachimsen L, Kuchlin S, Reich M, Gross NJ, Brandt AU, Schuchardt F, Harloff A, Bohringer D, Lagreze WA (2020) Optic nerve head volumetry by optical coherence tomography in papilledema related to idiopathic intracranial hypertension. Transl Vis Technol 9:24 Dreesbach M, Joachimsen L, Kuchlin S, Reich M, Gross NJ, Brandt AU, Schuchardt F, Harloff A, Bohringer D, Lagreze WA (2020) Optic nerve head volumetry by optical coherence tomography in papilledema related to idiopathic intracranial hypertension. Transl Vis Technol 9:24
104.
Zurück zum Zitat Lin Y, Chen S, Zhang M (2021) Peripapillary vessel density measurement of quadrant and clock-hour sectors in primary angle closure glaucoma using optical coherence tomography angiography. BMC Ophthalmol 21:328PubMedPubMedCentral Lin Y, Chen S, Zhang M (2021) Peripapillary vessel density measurement of quadrant and clock-hour sectors in primary angle closure glaucoma using optical coherence tomography angiography. BMC Ophthalmol 21:328PubMedPubMedCentral
105.
Zurück zum Zitat Mansoori T, Balakrishna N (2019) Peripapillary vessel density and retinal nerve fiber layer thickness in patients with unilateral primary angle closure glaucoma with superior hemifield defect. J Curr Glaucoma Pract 13:21–27PubMedPubMedCentral Mansoori T, Balakrishna N (2019) Peripapillary vessel density and retinal nerve fiber layer thickness in patients with unilateral primary angle closure glaucoma with superior hemifield defect. J Curr Glaucoma Pract 13:21–27PubMedPubMedCentral
106.
Zurück zum Zitat Borrelli E, Parravano M, Sacconi R, Costanzo E, Querques L, Vella G, Bandello F, Querques G (2020) Guidelines on optical coherence tomography angiography imaging: 2020 focused update. Ophthalmol Ther 9:697–707PubMedPubMedCentral Borrelli E, Parravano M, Sacconi R, Costanzo E, Querques L, Vella G, Bandello F, Querques G (2020) Guidelines on optical coherence tomography angiography imaging: 2020 focused update. Ophthalmol Ther 9:697–707PubMedPubMedCentral
107.
Zurück zum Zitat Tüntaş Bilen F, Atilla H (2019) Peripapillary vessel density measured by optical coherence tomography angiography in idiopathic intracranial hypertension. J Neuroophthalmol 39:319–323PubMed Tüntaş Bilen F, Atilla H (2019) Peripapillary vessel density measured by optical coherence tomography angiography in idiopathic intracranial hypertension. J Neuroophthalmol 39:319–323PubMed
108.
Zurück zum Zitat Yalcinkaya Cakir G, Solmaz B, Cakir I, Pasaoglu IB, Taskapili M (2024) Optical coherence tomography angiography findings in optic disc drusen and idiopathic intracranial hypertension. Eur J Ophthalmol 34:566–573PubMed Yalcinkaya Cakir G, Solmaz B, Cakir I, Pasaoglu IB, Taskapili M (2024) Optical coherence tomography angiography findings in optic disc drusen and idiopathic intracranial hypertension. Eur J Ophthalmol 34:566–573PubMed
109.
Zurück zum Zitat Kaya FS, Sonbahar O, Açar PA, Özbaş M, Yigit FU (2021) Evaulating peripapillary vessel density ın regressed papilledema ın ıdiopathic ıntracranial hypertension patients. Photodiagn Photodyn Ther 36:102551 Kaya FS, Sonbahar O, Açar PA, Özbaş M, Yigit FU (2021) Evaulating peripapillary vessel density ın regressed papilledema ın ıdiopathic ıntracranial hypertension patients. Photodiagn Photodyn Ther 36:102551
110.
Zurück zum Zitat Fard MA, Sahraiyan A, Jalili J, Hejazi M, Suwan Y, Ritch R, Subramanian PS (2019) Optical coherence tomography angiography in papilledema compared with pseudopapilledema. Invest Ophthalmol Vis Sci 60:168–175PubMedPubMedCentral Fard MA, Sahraiyan A, Jalili J, Hejazi M, Suwan Y, Ritch R, Subramanian PS (2019) Optical coherence tomography angiography in papilledema compared with pseudopapilledema. Invest Ophthalmol Vis Sci 60:168–175PubMedPubMedCentral
111.
Zurück zum Zitat Wang H, Cao L, Kwapong WR, Liu G, Wang R, Liu J, Wu B (2023) Optic nerve head changes measured by swept source optical coherence tomography and angiography in patients with intracranial hypertension. Ophthalmol Ther 12:3295–3305PubMedPubMedCentral Wang H, Cao L, Kwapong WR, Liu G, Wang R, Liu J, Wu B (2023) Optic nerve head changes measured by swept source optical coherence tomography and angiography in patients with intracranial hypertension. Ophthalmol Ther 12:3295–3305PubMedPubMedCentral
112.
Zurück zum Zitat Chonsui M, Le Goff M, Korobelnik JF, Rougier MB (2022) Quantitative analysis of radial peripapillary capillary network in patients with papilledema compared with healthy subjects using optical coherence tomography angiography. J Neuroophthalmol 42:e109–e115PubMed Chonsui M, Le Goff M, Korobelnik JF, Rougier MB (2022) Quantitative analysis of radial peripapillary capillary network in patients with papilledema compared with healthy subjects using optical coherence tomography angiography. J Neuroophthalmol 42:e109–e115PubMed
113.
Zurück zum Zitat Kwapong WR, Cao L, Pan R, Wang H, Ye C, Tao W, Liu J, Wu B (2023) Retinal microvascular and structural changes in intracranial hypertension patients correlate with intracranial pressure. CNS Neurosci Ther 29:4093–4101PubMedPubMedCentral Kwapong WR, Cao L, Pan R, Wang H, Ye C, Tao W, Liu J, Wu B (2023) Retinal microvascular and structural changes in intracranial hypertension patients correlate with intracranial pressure. CNS Neurosci Ther 29:4093–4101PubMedPubMedCentral
114.
Zurück zum Zitat Adhi M, Duker JS (2013) Optical coherence tomography—current and future applications. Curr Opin Ophthalmol 24:213–221PubMedPubMedCentral Adhi M, Duker JS (2013) Optical coherence tomography—current and future applications. Curr Opin Ophthalmol 24:213–221PubMedPubMedCentral
115.
Zurück zum Zitat Gabriele ML, Wollstein G, Ishikawa H, Kagemann L, Xu J, Folio LS, Schuman JS (2011) Optical coherence tomography: history, current status, and laboratory work. Invest Ophthalmol Vis Sci 52:2425–2436PubMedPubMedCentral Gabriele ML, Wollstein G, Ishikawa H, Kagemann L, Xu J, Folio LS, Schuman JS (2011) Optical coherence tomography: history, current status, and laboratory work. Invest Ophthalmol Vis Sci 52:2425–2436PubMedPubMedCentral
116.
Zurück zum Zitat Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73:302–308PubMedPubMedCentral Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73:302–308PubMedPubMedCentral
117.
Zurück zum Zitat Stricker S, Oberwahrenbrock T, Zimmermann H, Schroeter J, Endres M, Brandt AU, Paul F (2011) Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS ONE 6:e23024PubMedPubMedCentral Stricker S, Oberwahrenbrock T, Zimmermann H, Schroeter J, Endres M, Brandt AU, Paul F (2011) Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS ONE 6:e23024PubMedPubMedCentral
118.
Zurück zum Zitat Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24–29PubMed Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24–29PubMed
119.
Zurück zum Zitat Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9:921–932PubMed Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9:921–932PubMed
120.
Zurück zum Zitat Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT (2005) The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 24:39–73PubMed Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT (2005) The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 24:39–73PubMed
121.
Zurück zum Zitat Bellezza AJ, Hart RT, Burgoyne CF (2000) The optic nerve head as a biomechanical structure: initial finite element modeling. Invest Ophthalmol Vis Sci 41:2991–3000PubMed Bellezza AJ, Hart RT, Burgoyne CF (2000) The optic nerve head as a biomechanical structure: initial finite element modeling. Invest Ophthalmol Vis Sci 41:2991–3000PubMed
122.
Zurück zum Zitat Strouthidis NG, Fortune B, Yang H, Sigal IA, Burgoyne CF (2011) Effect of acute intraocular pressure elevation on the monkey optic nerve head as detected by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 52:9431–9437PubMedPubMedCentral Strouthidis NG, Fortune B, Yang H, Sigal IA, Burgoyne CF (2011) Effect of acute intraocular pressure elevation on the monkey optic nerve head as detected by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 52:9431–9437PubMedPubMedCentral
123.
Zurück zum Zitat Liu Z, Dong C, Wang X, Han X, Zhao P, Lv H, Li Q, Wang Z (2015) Association between idiopathic intracranial hypertension and sigmoid sinus dehiscence/diverticulum with pulsatile tinnitus: a retrospective imaging study. Neuroradiology 57:747–753PubMed Liu Z, Dong C, Wang X, Han X, Zhao P, Lv H, Li Q, Wang Z (2015) Association between idiopathic intracranial hypertension and sigmoid sinus dehiscence/diverticulum with pulsatile tinnitus: a retrospective imaging study. Neuroradiology 57:747–753PubMed
124.
Zurück zum Zitat Prabhat N, Kaur K, Takkar A, Ahuja C, Katoch D, Goyal M, Dutta P, Bhansali A, Lal V (2024) Pituitary dysfunction in idiopathic intracranial hypertension: an analysis of 80 patients. Can J Neurol Sci 51:265–271PubMed Prabhat N, Kaur K, Takkar A, Ahuja C, Katoch D, Goyal M, Dutta P, Bhansali A, Lal V (2024) Pituitary dysfunction in idiopathic intracranial hypertension: an analysis of 80 patients. Can J Neurol Sci 51:265–271PubMed
125.
Zurück zum Zitat Falsini B, Tamburrelli C, Porciatti V, Anile C, Porrello G, Mangiola N (1992) Pattern electroretinograms and visual evoked potentials in idiopathic intracranial hypertension. Ophthalmologica 205:194–203PubMed Falsini B, Tamburrelli C, Porciatti V, Anile C, Porrello G, Mangiola N (1992) Pattern electroretinograms and visual evoked potentials in idiopathic intracranial hypertension. Ophthalmologica 205:194–203PubMed
126.
Zurück zum Zitat Madill SA, Connor SE (2005) Computed tomography demonstrates short axial globe length in cases with idiopathic intracranial hypertension. J Neuroophthalmol 25:180–184PubMed Madill SA, Connor SE (2005) Computed tomography demonstrates short axial globe length in cases with idiopathic intracranial hypertension. J Neuroophthalmol 25:180–184PubMed
127.
Zurück zum Zitat Yadav SK, Kadas EM, Motamedi S, Polthier K, Haußer F, Gawlik K, Paul F, Brandt A (2018) Optic nerve head three-dimensional shape analysis. J Biomed Opt 23:1–13PubMed Yadav SK, Kadas EM, Motamedi S, Polthier K, Haußer F, Gawlik K, Paul F, Brandt A (2018) Optic nerve head three-dimensional shape analysis. J Biomed Opt 23:1–13PubMed
128.
Zurück zum Zitat Mittra RA, Sergott RC, Flaharty PM, Lieb WE, Savino PJ, Bosley TM, Hedges TR Jr (1993) Optic nerve decompression improves hemodynamic parameters in papilledema. Ophthalmology 100:987–997PubMed Mittra RA, Sergott RC, Flaharty PM, Lieb WE, Savino PJ, Bosley TM, Hedges TR Jr (1993) Optic nerve decompression improves hemodynamic parameters in papilledema. Ophthalmology 100:987–997PubMed
129.
Zurück zum Zitat Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246:1029–1046PubMedPubMedCentral Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246:1029–1046PubMedPubMedCentral
130.
Zurück zum Zitat Sharma S, Ang M, Najjar RP, Sng C, Cheung CY, Rukmini AV, Schmetterer L, Milea D (2017) Optical coherence tomography angiography in acute non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 101:1045–1051PubMed Sharma S, Ang M, Najjar RP, Sng C, Cheung CY, Rukmini AV, Schmetterer L, Milea D (2017) Optical coherence tomography angiography in acute non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 101:1045–1051PubMed
131.
Zurück zum Zitat Mohammadi S, Gouravani M, Salehi MA, Arevalo JF, Galetta SL, Harandi H, Frohman EM, Frohman TC, Saidha S, Sattarnezhad N, Paul F (2023) Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis. J Neuroinflamm 20:85 Mohammadi S, Gouravani M, Salehi MA, Arevalo JF, Galetta SL, Harandi H, Frohman EM, Frohman TC, Saidha S, Sattarnezhad N, Paul F (2023) Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis. J Neuroinflamm 20:85
132.
Zurück zum Zitat Borrelli E, Balasubramanian S, Triolo G, Barboni P, Sadda SR, Sadun AA (2018) Topographic macular microvascular changes and correlation with visual loss in chronic leber hereditary optic neuropathy. Am J Ophthalmol 192:217–228PubMed Borrelli E, Balasubramanian S, Triolo G, Barboni P, Sadda SR, Sadun AA (2018) Topographic macular microvascular changes and correlation with visual loss in chronic leber hereditary optic neuropathy. Am J Ophthalmol 192:217–228PubMed
133.
Zurück zum Zitat Malhotra K, Padungkiatsagul T, Moss HE (2020) Optical coherence tomography use in idiopathic intracranial hypertension. Ann Eye Sci 5:7PubMedPubMedCentral Malhotra K, Padungkiatsagul T, Moss HE (2020) Optical coherence tomography use in idiopathic intracranial hypertension. Ann Eye Sci 5:7PubMedPubMedCentral
134.
Zurück zum Zitat Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1–55PubMed Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1–55PubMed
135.
Zurück zum Zitat Querfurth HW, Lagrèze WD, Hedges TR, Heggerick PA (2002) Flow velocity and pulsatility of the ocular circulation in chronic intracranial hypertension. Acta Neurol Scand 105:431–440PubMed Querfurth HW, Lagrèze WD, Hedges TR, Heggerick PA (2002) Flow velocity and pulsatility of the ocular circulation in chronic intracranial hypertension. Acta Neurol Scand 105:431–440PubMed
136.
Zurück zum Zitat Skau M, Milea D, Sander B, Wegener M, Jensen R (2011) OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 249:723–730PubMed Skau M, Milea D, Sander B, Wegener M, Jensen R (2011) OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 249:723–730PubMed
137.
Zurück zum Zitat Afonso CL, Raza AS, Kreuz AC, Hokazono K, Cunha LP, Oyamada MK, Monteiro ML (2015) Relationship between pattern electroretinogram, frequency-domain OCT, and automated perimetry in chronic papilledema from pseudotumor cerebri syndrome. Invest Ophthalmol Vis Sci 56:3656–3665PubMed Afonso CL, Raza AS, Kreuz AC, Hokazono K, Cunha LP, Oyamada MK, Monteiro ML (2015) Relationship between pattern electroretinogram, frequency-domain OCT, and automated perimetry in chronic papilledema from pseudotumor cerebri syndrome. Invest Ophthalmol Vis Sci 56:3656–3665PubMed
138.
Zurück zum Zitat Banerjee M, Phuljhele S, Saluja G, Kumar P, Saxena R, Sharma P, Vibha D, Pandit AK (2022) Optical coherence tomography features and correlation of functional and structural parameters in patients of idiopathic intracranial hypertension. Indian J Ophthalmol 70:1343–1349PubMedPubMedCentral Banerjee M, Phuljhele S, Saluja G, Kumar P, Saxena R, Sharma P, Vibha D, Pandit AK (2022) Optical coherence tomography features and correlation of functional and structural parameters in patients of idiopathic intracranial hypertension. Indian J Ophthalmol 70:1343–1349PubMedPubMedCentral
139.
Zurück zum Zitat Thaller M, Homer V, Hyder Y, Yiangou A, Liczkowski A, Fong AW, Virdee J, Piccus R, Roque M, Mollan SP, Sinclair AJ (2023) The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol 270:851–863PubMed Thaller M, Homer V, Hyder Y, Yiangou A, Liczkowski A, Fong AW, Virdee J, Piccus R, Roque M, Mollan SP, Sinclair AJ (2023) The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol 270:851–863PubMed
140.
Zurück zum Zitat Rodriguez Torres Y, Lee P, Mihlstin M, Tomsak RL (2021) Correlation between optic disc peripapillary capillary network and papilledema grading in patients with idiopathic intracranial hypertension: a study of optical coherence tomography angiography. J Neuroophthalmol 41:48–53PubMed Rodriguez Torres Y, Lee P, Mihlstin M, Tomsak RL (2021) Correlation between optic disc peripapillary capillary network and papilledema grading in patients with idiopathic intracranial hypertension: a study of optical coherence tomography angiography. J Neuroophthalmol 41:48–53PubMed
141.
Zurück zum Zitat El-Haddad N, Ismael SA, El-Wahab AA, Shalaby S, Farag MMA, Mohammd NS, Shawky S (2023) Optic disc vessel density changes after shunt surgery in idiopathic intracranial hypertension. Photodiagn Photodyn Ther 42:103625 El-Haddad N, Ismael SA, El-Wahab AA, Shalaby S, Farag MMA, Mohammd NS, Shawky S (2023) Optic disc vessel density changes after shunt surgery in idiopathic intracranial hypertension. Photodiagn Photodyn Ther 42:103625
Metadaten
Titel
Exploring the utility of retinal optical coherence tomography as a biomarker for idiopathic intracranial hypertension: a systematic review
verfasst von
Mallika Prem Senthil
Saumya Anand
Ranjay Chakraborty
Jose Estevez Bordon
Paul A. Constable
Shannon Brown
Dalia Al-Dasooqi
Simu Simon
Publikationsdatum
10.06.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2024
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-024-12481-3

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

CGRP-Antikörper auch bei älteren Migränekranken sicher

Beginnen ältere Migränekranke eine Prophylaxe mit CGRP-Antikörpern, kommt es anschließend nicht häufiger zu kardiovaskulären Problemen als unter einer Prophylaxe mit Botulinumtoxin. Darauf deutet eine US-Analyse von Medicare-Versicherten.

Frühwarnzeichen für multiple Sklerose bei Kindern und Jugendlichen

Ein Forschungsteam aus Deutschland und Kanada hat eine Reihe metabolischer, okulärer, muskuloskelettaler, gastrointestinaler und kardiovaskulärer Symptome identifiziert, die bei Kindern und Jugendlichen der Diagnose einer multiplen Sklerose (MS) vorausgehen können.

Migräne verstehen und psychotherapeutisch behandeln

Das Wissen über die Mechanismen, die im Gehirn bei einer Migräneattacke ablaufen, und mögliche Auslöser wird immer breiter. Der psychologische Psychotherapeut Dr. Dipl.-Psych. Timo Klan fasst den aktuellen Erkenntnisstand zusammen. Und er gibt Tipps für eine differenzierte, individuelle Diagnostik auch von Begleiterkrankungen und beschreibt erfolgreiche psychotherapeutische Interventionen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.